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ABSTRACT 
 
Environmental mastitis is of increasing prevalence in well managed dairy 
herds throughout the world. Of the environmental pathogens, Streptococcus 
uberis is one of the most prevalent, accounting for a significant proportion of 
clinical and subclinical intramammary infections in lactating and nonlactating 
dairy cows and heifers. In spite of this, the pathogenesis of S. uberis mastitis is 
not well understood. The objective of this study was to determine dynamics of 
leukocytes and cytokines during experimentally-induced S. uberis mastitis. Five 
Jersey and 5 Holstein cows were challenged via intramammary inoculation with 
S. uberis into 2 uninfected mammary glands. One uninfected unchallenged 
mammary gland from each cow served as a negative control. Rectal 
temperatures, blood and milk samples were collected frequently for one week 
after challenge. Clinical status of mammary glands was recorded twice daily 
during milking. Milk samples were collected to enumerate bacteria and somatic 
cells, and to determine concentrations of tumor necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and interleukin-8 (IL-8). Neutrophils were isolated from 
blood to determine expression of CD11b, CD18 and CD62 during the course of 
experimental infection. Sixteen of 20 challenged mammary glands developed 
clinical mastitis between 84 and 108 hours after intramammary challenge, and 
peak clinical signs of mastitis were observed at 144 hours. The number of S. 
uberis in milk from challenged mammary glands increased significantly (P<0.05) 
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by 48 hours after challenge, in spite of a massive leukocyte infiltration from the 
bloodstream, evidenced by an increase in the number of somatic cells in milk 
which began at 18 hours after challenge (P<0.001) and remained elevated 
throughout the study period. Significant amounts of TNF-α, IL-1β and IL-8 in milk 
were detected 66 hours after challenge (P<0.05). Peak concentrations of TNF-α 
were observed at 120 hours after challenge, preceding peak clinical signs.  
Concentrations of IL-1β in mammary secretions fluctuated considerably from 66 
to 144 hours after challenge, but were significantly higher (P<0.01) than 
prechallenge values and values found in milk from control mammary glands. 
Similar to TNF-α, peak IL-8 concentrations were observed at 120 hours after 
challenge. The 4 challenged mammary glands that did not become infected 
exhibited an increase in somatic cells and IL-1β concentrations in a pattern that 
appeared to be similar to that of challenged infected mammary glands, but of 
lesser magnitude. Expression of CD11b was upregulated at 84, 90 and 114 
hours after challenge (P<0.05), and expression of CD18 was increased 20% at 
48 hours after challenge (P<0.05). Expression of CD18 decreased sharply 96 
hours after challenge and remained depressed until the end of the sampling 
period (P<0.01). Results from this experiment demonstrated that S. uberis 
experimental intramammary infection induced local production of TNF-α, IL-1β 
and IL-8, which may play a role in the pathogenesis of S. uberis mastitis. 
Furthermore, an increase in somatic cells in milk occurred earlier than increases 
in adhesion molecule expression or cytokine production, suggesting that other 
  vii 
mediators may be involved in initial leukocyte recruitment into the mammary 
gland after infection. 
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Chapter 1 
INTRODUCTION 
 
Bovine mastitis is the most common and expensive disease affecting dairy 
cows throughout the world. This disease is typically caused by bacteria and 
characterized by inflammation of the mammary gland and abnormal appearance 
of lacteal secretions regardless of the etiologic agent. As a result of mastitis, both 
milk yield and milk quality are affected greatly. Reduced milk yield and alterations 
in milk composition due to mastitis are influenced by the severity of the 
inflammatory response, which in turn is influenced by the mastitis pathogen 
causing the infection (Oliver and Calvinho, 1995). The National Mastitis Council 
estimated that mastitis costs dairy producers in the U.S. $2 billion annually 
(National Mastitis Council, 1996). Therefore, mastitis continues to be the most 
significant limiting factor to profitable dairy production worldwide. 
Signs of mastitis vary according to severity and duration of infection. 
Intramammary infection (IMI) may result in clinical or subclinical disease. 
Mammary glands with subclinical mastitis show no obvious signs of disease. Milk 
from cows with subclinical mastitis appears normal; however, microorganisms 
and inflammatory cells are present in high numbers. In many herds, subclinical 
mastitis is by far the most prevalent and causes the greatest overall loss due to 
lowered milk production (National Mastitis Council, 1996). Clinical mastitis, on the 
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other hand, is characterized by abnormal milk, such as clots and clumps, and/or 
visible alterations of the udder, such as redness and swelling. In severe cases, 
there may be systemic signs such as elevated temperature, anorexia and 
septicemia, which may cause death of the animal (Leigh, 1999).  
Over 135 infectious agents have been associated with clinical mastitis 
(Watts, 1988). Mastitis causing organisms have been categorized as contagious 
or environmental pathogens based on their distinct characteristics of distribution 
and interaction with the teat and teat duct (Calvinho et al., 1998). Contagious 
pathogens live and multiply in the cows mammary gland and are spread from 
animal to animal primarily during milking. Environmental pathogens are those 
whose primary reservoir is the environment where cows live and not infected 
mammary glands (Smith and Hogan, 1993). Contagious pathogens include 
Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma species and 
Corynebacterium bovis, while environmental pathogens include a heterogeneous 
group of bacterial genera, species and strains (Calvinho et al., 1998). The most 
frequently isolated environmental pathogens are streptococci other than S. 
agalactiae (environmental streptococci) and Gram-negative bacteria (Smith et al., 
1985; Oliver, 1988; Smith and Hogan, 1993).  
Control of bovine mastitis is very difficult due to the diversity of pathogens 
capable of causing the disease. Mastitis is present in every herd; however, rates 
of infection and types of bacteria causing mastitis vary tremendously between 
herds (Oliver and Mitchell, 1984). Current mastitis control programs developed in 
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the late 1960s are aimed at reducing the prevalence of mastitis by reducing the 
incidence, duration and likelihood of transmission of an infection. Therefore, the 
greatest control has been achieved against those pathogens transmitted from 
cow to cow. These control programs are based on hygiene including pre- and 
postmilking teat disinfection, therapeutic and prophylactic antibiotic therapy and 
culling of chronically infected cows. Acceptance and application of these 
measures has led to considerable progress in controlling contagious mastitis 
pathogens. However, these measures have been less effective against 
environmental pathogens (Smith et al., 1985). Consequently, environmental 
mastitis has become a major problem, particularly in well-managed dairy herds 
that have successfully controlled contagious pathogens (Oliver and Mitchell, 
1984; Oliver, 1988; Bennet, 1990; Todhunter et al., 1995). It has been 
hypothesized that the niche vacated by contagious mastitis pathogens becomes 
occupied by environmental mastitis pathogens, resulting in an increased 
prevalence of environmental pathogen IMI (Jayarao et al., 1999). Among the 
environmental streptococci, Streptococcus uberis is the most prevalent, 
accounting for a significant proportion of subclinical and clinical IMI in both 
lactating and nonlactating cows (Smith et al., 1985; Oliver, 1988; Todhunter et 
al., 1995; Jayarao et al., 1999; Phuektes et al., 2001).  
Therapeutic and prophylactic antibiotic therapy for the control of mastitis 
presents three major concerns. Firstly, bacteriologic cure rates for therapy during 
lactation are not as high as in vitro sensitivity data would indicate (Keefe and 
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Leslie, 1997). Secondly, the presence of antibiotic residues in milk for human 
consumption is a major concern in todays dairy industry, and mastitis is the 
number one cause of antibiotic use in dairy cows (Moore and Heider, 1984). 
Thirdly, there is concern that widespread use of antibiotics for treatment and 
prevention of mastitis will increase the risk of antibiotic resistance of pathogens 
that can cause disease in humans. The desire to protect hypersensitive 
individuals from exposure to specific antibiotics and to reduce the remote 
possibility of the emergence of antibiotic resistant organisms in milk or in human 
enteric flora has led to strict and extensive surveillance programs for detection of 
antibiotic residues in milk (Allison, 1985). Although the risk to human health from 
antibiotic residues in milk is negligible, sectors of society object to being 
involuntarily exposed to drug residues. Limiting the use of antibiotics to treat 
mastitis would greatly benefit dairy farmers, since discarded milk during antibiotic 
treatment together with decreased milk production account for the largest 
economic losses associated with mastitis (National Mastitis Council, 1996). 
Based on limitations of current methods of mastitis control and concerns 
regarding use of antibiotics in food producing animals, it seems appropriate to 
consider alternative non-antibiotic methods for the prevention and control of 
environmental mastitis. In addition to the required practices of good herd 
management and hygiene, alternative control measures should include 
manipulation of host defense mechanisms. This approach requires knowledge of 
host and pathogen factors involved in the development and establishment of IMI 
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as well as defense mechanisms within the udder and ways to enhance these 
mechanisms (Calvinho et al., 1998). However, the pathogenesis of S. uberis 
mastitis is incompletely understood. More insight into mechanisms of IMI by S. 
uberis will ultimately lead to more successful control and prevention of S. uberis 
mastitis in dairy cows.  
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Chapter 2 
LITERATURE REVIEW 
 
CHARACTERISTICS OF STREPTOCOCCUS UBERIS 
 
Epidemiology  
Streptococcus uberis is ubiquitous in the cows environment (Smith et al., 
1985). It has been isolated from many sites of the cow including tonsils, genital 
tract, rumen, rectum and skin (Kruze and Bramley, 1982). However, this 
organism does not contribute significantly to disease outside the mammary 
gland. It would appear that S. uberis has evolved to become a successful and 
specialized pathogen of the bovine mammary gland (Leigh, 1997).  The organism 
can also be isolated in high numbers from bedding material used for cattle 
(Bramley, 1982), which is thought to act as an important vector that can 
contaminate teats. Furthermore, S. uberis has been isolated from heavily used 
pasture in numbers similar to those seen in bedding materials (Harmon et al., 
1992).  
Intramammary infection with S. uberis is common throughout the world. A 
review by Hogan and Smith (1997) cited four surveys conducted in the previous 
10 years in Canada, Ohio, the Netherlands and the United Kingdom, which 
indicated that S. uberis was responsible for 14 to 26% of all clinical mastitis 
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cases. Interestingly, S. uberis is also a significant cause of bovine mastitis in 
New Zealand, Australia and Argentina, where the dairy industry is primarily 
pasture based (Williamson et al., 1995; Pankey et al., 1996; Acuña et al., 2001; 
Phuektes et al., 2001).  
 
Biochemical and serological characteristics 
Streptococcus uberis is identified routinely on the basis of colony 
morphology and esculin hydrolysis; however, subsequent culture confirmation 
requires additional tests. One of the most widely used systems for the 
identification of streptococci is the API 20 Strep System (bioMerieux, Vitek Inc.), 
which consists of 20 miniaturized biochemical tests in a plastic strip. In a study by 
Jayarao et al. (1991b), this system identified 57 of 60 S. uberis isolates correctly. 
In the same study, the Vitek Gram-positive identification system (GPI, Vitek 
Systems), using 15 miniaturized biochemical tests, also correctly identified 57 of 
60 isolates.  
Streptococcus uberis is serologically heterogeneous. Jayarao et al. 
(1991b) used a streptococcal agglutination system containing Lancefield group 
A-, B-, C-, D-, F- and G-specific antibodies to determine serogroups of 60 S. 
uberis isolates. Although 16 isolates were classified as belonging to serogroup G, 
the remaining isolates did not belong to any of the serogroups tested. 
Consequently, serological tests appear to be of little value for identification of S. 
uberis (Leigh, 1999). 
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Molecular biology techniques 
Using chromosomal DNA hybridization, Garvie and Bramley (1979) 
demonstrated the presence of two S. uberis genotypes (types I and II). Williams 
and Collins (1990) determined the nucleotide sequences for 16S ribosomal RNA 
of S. uberis genotypes I and II and showed that the two genotypes were 
phyolgenetically distinct and proposed that S. uberis genotype II be designated 
Streptococcus parauberis. However, cultural, morphological, biochemical and 
serological characteristics of the two closely related species are 
indistinguishable. Techniques developed by Jayarao et al. (1991a; 1992b) based 
on restriction fragment length polymorphism (RFLP) of polymerase chain 
reaction (PCR) amplified 16S rRNA genes, indicated that the predominant 
organism isolated from infected mammary glands was S. uberis and that S. 
parauberis occurred infrequently (Oliver et al., 1998). 
A number of techniques have been investigated for differentiation and 
subtyping of individual S. uberis strains. Restriction endonuclease fingerprinting 
of chromosomal DNA (Jayarao et al., 1991c), rRNA gene (rDNA) restriction 
patterns (Williams and Collins, 1991; Jayarao et al., 1992b) and DNA 
amplification fingerprinting (Jayarao et al., 1992a) have been shown to be useful 
procedures for typing S. uberis. Each procedure has confirmed the wide variety 
of strains which are able to infect the mammary gland and substantiates the view 
that S. uberis IMI do not result from contagious transmission of a limited number 
of virulent strains within a herd (Leigh, 1999). 
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Virulence factors 
For IMI to occur, mechanisms associated with avoidance of phagocytic 
defenses, adherence to epithelial cells and colonization of mammary gland tissue 
are probably present (Oliver et al., 1998). By various mechanisms, S. uberis is 
capable of finding beneficial conditions for growth and avoidance of mammary 
gland defense systems. Potential virulence factors and pathogenic mechanisms 
for S. uberis are presented in Table 1.  
 
1- Capsule 
Avoidance of phagocytosis is probably one of the more important mechanisms 
that bacterial pathogens possess to establish an IMI. Bacterial capsules exert 
their antiphagocytic functions through mechanisms such as electrostatic 
repulsion, antigenic mimicry and low immunogenicity, antigen masking, physical 
barrier between bacteria and phagocyte, binding and depletion of opsonic factors 
and suppression of phagocyte cell activity (Speert et al., 1983; Almeida et al., 
1992). Matthews et al. (1994b) reported that about 50% of S. uberis isolates 
were encapsulated. Almeida and Oliver (1993b) characterized two forms of 
capsular material from S. uberis composed primarily of hyaluronic acid; a higher 
molecular weight form associated with the bacterial cell and a lower molecular 
weight form that apparently was released to the surrounding environment. 
  10 
Table 1. Potential virulence factors of Streptococcus uberis. 1 
Virulence factor Reference 
Cell associated factors/activity  
Adherence (Almeida et al., 1996; Almeida et al., 1999a; Almeida 
et al., 1999b) 
Lactoferrin-binding protein (Fang and Oliver, 1999) 
Collagen-binding protein (Gilbert et al., 1997) 
Fibronectin-binding (Almeida et al., 1996) 
Hyaluronic acid capsule (Almeida and Oliver, 1993a; Almeida and Oliver, 
1993b; Matthews et al., 1994b) 
Invasion (Matthews et al., 1994a) 
Laminin-binding (Almeida et al., 1996) 
M-like protein (Almeida et al., 1996) 
PMN toxin (Leigh, 1994a) 
R-like protein (Groschup and Timoney, 1993) 
Plasminogen activator (Leigh, 1994b) 
Extracellular factors  
Hyaluronic acid capsule (Almeida and Oliver, 1993b) 
Hyaluronidase (Schaufuss et al., 1989) 
Uberis factor (Skalka et al., 1980) 
1adapted from Oliver et al., 1998. 
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Conflicting reports exist on the role of the capsule in resistance of S. 
uberis to phagocytosis, especially by bovine macrophages. In a study by Grant 
and Finch (1996), two strains of S. uberis that differed in their ability to produce 
capsule and to resist phagocytosis and killing by neutrophils were both shown to 
be phagocytosed and killed equally by bovine macrophages. However, Almeida 
and Oliver (1993a; 1995) reported that phagocytosis and intracellular killing by 
bovine mammary macrophages was significantly higher for nonencapsulated 
strains than for encapsulated strains of S. uberis. Furthermore, when 
encapsulated bacteria were opsonized by anticapsular antibodies, the 
antiphagocytic effect was inhibited (Almeida and Oliver, 1993a). Purified, 
protease-treated capsular material diminished macrophage phagocytic and killing 
activity, and this suppressive effect not only protected encapsulated strains but 
also protected nonencapsulated strains of S. uberis from macrophage 
phagocytosis (Almeida and Oliver, 1993a). 
One of the general mechanisms that has been proposed to explain the 
role of capsular components in resistance of bacteria to phagocytosis is that the 
capsule may prevent binding of opsonic factors such as antibody or complement 
to the bacterial cell (Horrowitz and Silverstein, 1980). A capsular and non-
capsular phenotype of the same strain of S. uberis were shown to bind equal 
quantities of antibody (Leigh and Field, 1994). In each case, the antibody was 
intact, bound in the correct orientation and presented the Fc terminus for 
interaction with receptors on phagocytic cells (Leigh and Field, 1994). Leigh and 
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Field (1994) suggested that resistance of S. uberis to bactericidal action of 
bovine neutrophils was not related to bound immunoglobulins. In this study, 
however, bovine mammary macrophages were not evaluated, and there was no 
indication of whether antiserum reacted against capsular material of S. uberis.  
 
2- Plasminogen activator 
Streptococcus uberis is highly auxotrophic and depends on acquisition of 
several amino acids, vitamins, trace elements and a carbohydrate source to grow 
successfully (Leigh, 1994b). Since milk from lactating mammary glands is 
deficient in free or peptide associated amino acids, S. uberis must possess a 
mechanism to acquire amino acids for growth. Leigh (1993) demonstrated that S. 
uberis was capable of converting plasminogen to plasmin, which in turn 
degraded casein and generated by-products needed for optimal bacterial growth. 
A plasminogen activator, designated PauA, was isolated from S. uberis (Leigh, 
1994b). However, the relationship between activation of plasminogen and 
virulence is not clear since a low pathogenic strain which showed caseinolytic 
activity (Leigh et al., 1990) was susceptible to killing by bovine neutrophils after 
growth in medium supplemented with casein (Leigh and Field, 1991). 
Results from a vaccination study using PauA suggest that this molecule 
conferred partial protection against experimentally induced S. uberis mastitis in 
dairy cows (Leigh et al., 1999). Three of four animals vaccinated with PauA 
showed no signs of clinical mastitis, and bacterial shedding in milk was low (<103 
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colony forming units/ml of milk) in 5 of the 6 challenged quarters (Leigh et al., 
1999). The 5 quarters that resisted clinical infection showed the highest antibody 
titre to PauA. Furthermore, protection was not associated with influx of large 
numbers of neutrophils into the mammary gland, evidenced by somatic cell 
counts for challenged quarters from vaccinated animals that never exceeded 2 x 
105 cells/ml of milk (Leigh et al., 1999). These results indicate that although 
establishment of infection could not be avoided, challenged quarters of 
vaccinated cows did not develop clinical mastitis, probably by reduction in the 
rate of colonization of the gland. 
 
3- Lactoferrin-binding proteins 
Streptococcus uberis expresses at least two surface proteins, designated 
lactoferrin-binding proteins, that bind to lactoferrin (Lf) in milk (Fang and Oliver, 
1999). Lactoferrin is an iron-binding protein present in bovine milk which 
increases dramatically in concentration during involution and during infection of 
the bovine mammary gland (Smith and Oliver, 1981). Additionally, bovine Lf has 
been found to bind to several types of host cells, including bovine mammary 
epithelial cells (Rejman et al., 1994). Because S. uberis bound to Lf in milk and  
to purified Lf, it was hypothesized that Lf acted as a bridging molecule between 
bacteria and mammary epithelial cells or phagocytic cells in the pathogenesis of 
S. uberis mastitis (Fang and Oliver, 1999). More recently, Fang et al. (2000) 
demonstrated that presence of Lf in the culture medium and in milk enhanced 
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adherence of S. uberis to mammary epithelial cells, providing further evidence to 
substantiate this hypothesis. Lactoferrin-binding proteins have also been 
detected in S. dysgalactiae subspecies dysgalactiae and S. agalactiae isolated 
from cows with mastitis (Park et al., 2002). 
 
4- Adherence of S. uberis to mammary epithelium and to extracellular 
matrix proteins 
A common concept in the pathogenesis of infectious diseases is that 
microorganisms that infect mucosal surfaces should adhere to these surfaces to 
allow multiplication and colonization of that specific mucosa. Adherence should 
be strong enough to resist the flushing effect of normal secretions, and 
sufficiently specific to provide the microorganism with sources of nutrients that 
support colonization and spreading of the infection (Oliver et al., 1998).  
Hasty et al. (1992) proposed a multi-step model for adherence of 
Streptococcus species to epithelial cells which involved two distinct kinetic steps 
with different affinity interactions between host receptors and bacterial adhesins. 
In the first step, adherence was weak and of low specificity and involved 
electrostatic/hydrophobic interactions. Lipoteichoic acid (LTA) was proposed as 
the model adhesin of this step. The second step involved a strong adhesin-host 
receptor interaction, was non-hydrophobic, and involved highly specific bacterial 
cell ligand-host cell receptor interactions. It also provided stability to the 
attachment between bacteria and host cells. M protein and other ligands such as 
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fibronectin-binding protein and vitronectin-binding protein were proposed as the 
main adhesins involved in this step (Hasty et al., 1992). 
Almeida et al. (1996) showed that M protein and LTA contributed to 
adherence of S. uberis to mammary epthelial cells and suggested participation of 
the eukaryotic cell cytoskeleton and interaction between epithelial cell 
membranes and S. uberis. In addition, Almeida et al. (1996) indicated that S. 
uberis bound to extracellular matrix proteins (ECMP). A nonencapsulated strain 
of S. uberis adhered significantly better to mammary epithelial cells, but an 
encapsulated strain adhered better to laminin, collagen and fibronectin. Of the 
three ECMP tested in the study by Almeida et al.(1996), both strains showed 
greater binding to laminin. This agrees with Fillipsen et al. (1990) who showed 
adherence of S. uberis to ECMP and with Thomas et al. (1992) who indicated 
that adherence of S. uberis occurred where the endothelium was coated with 
fibrin. Gilbert et al. (1997) suggested that laminin, collagen and bovine mammary 
epithelial cells exert a positive regulation on S. uberis which leads to increased 
synthesis of specific proteins, and that these proteins are probably expressed in 
vivo during infection. Additionally, incubation of S. uberis with ECMP resulted in 
increased adherence to bovine mammary epithelial cells (Almeida et al., 1999b). 
Therefore, it is likely that ECMP exert a positive regulation and expression of 
virulence factors in S. uberis that enhances colonization of mammary epithelial 
cells (Almeida et al., 1999b). 
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5- Streptococcus uberis invasion of mammary epithelial cells 
Matthews et al. (1994a) demonstrated that S. uberis invaded bovine 
mammary epithelial cells based on ultrastructural changes in the mammary 
epithelial cells cytoplasmic membrane when S. uberis was in close proximity or 
made contact. Endocytic-like invaginations and development of pseudopod-like 
elongations that extended around and engulfed bacteria were evident where S. 
uberis interacted with epithelial cells. Internalized bacteria were observed 
enclosed in membrane-bound vacuoles (Matthews et al., 1994a). The invasion 
process involved mammary cell cytoskeleton elements, specifically F-actin. 
However, no morphological changes indicative of cell damage were observed 
following bacterial invasion (Matthews et al., 1994a). Data from experimental 
infection of bovine mammary glands showed S. uberis penetrating secretory 
epithelium 18 to 24 hours after infection (Thomas et al., 1994), further supporting 
the findings of in vitro studies. 
Invasion of mammary epithelial cells by S. uberis seems to require de 
novo synthesis of several bacterial proteins (Matthews et al., 1994c). 
Streptococcus uberis synthesized several new bacterial proteins when cocultured 
with bovine mammary epithelial cells (Matthews et al., 1994c; Fang et al., 
1998b). When bacterial protein synthesis was inhibited in coculture with 
mammary epithelial cells, the ability of S. uberis to invade mammary epithelial 
cells decreased (Matthews et al., 1994c). The ability of S. uberis in vivo to invade 
bovine mammary epithelial cells could result in chronic infections, since 
  17 
internalized bacteria are protected from host defense mechanisms and from the 
action of most antimicrobials (Oliver et al., 1998).  
 
THE INFLAMMATORY RESPONSE IN THE MAMMARY GLAND 
 
Mammary gland immunity 
Defense of the mammary gland against mastitis-causing pathogens is 
mediated by several anatomical, cellular and soluble protective factors (Sordillo 
et al., 1997). Once bacteria successfully penetrate the teat orifice, the efficiency 
of these mechanisms determines the resistance or susceptibility of the mammary 
gland to the establishment of new IMI. 
 
1- Anatomical defenses 
Almost invariably, mastitis occurs when bacteria gain entrance into the 
mammary gland through the teat canal. The teat canal is typically sealed 
between milkings by a keratin plug derived from epithelial cells lining the canal.  
Some components of the keratin plug have known microbicidal activity (Treece et 
al., 1966), but the major role of this plug is to serve as a physical barrier 
preventing microbial access to the teat sinus (Capuco et al., 1992).  
The teat end contains involuntary sphincter muscles that maintain tight 
closure between milkings and prevent bacteria from penetrating into the gland 
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(Hamann and Burvenich, 1994). The importance of the teat canal in prevention of 
IMI was documented as early as 1953 (Murphy and Stuart, 1953). Under the best 
of machine milking conditions, the process of milk accumulation and withdrawal 
from the gland leaves the involuntary teat sphincter muscle in a flaccid state that 
requires up to 2 hours for muscular tone to return (Schultze and Bright, 1983). 
Once this musculature contracts to close the teat end, it forms an effective seal 
of the streak canal and enables reformation of the keratin plug. Increased 
patency of the teat sphincter muscles is directly related to incidence of mastitis 
(Murphy and Stuart, 1953). Additionally, teat end lesions can be induced by a 
variety of traumatic insults, such as improper milking machine performance, 
chemical damage from teat dips and exposure to cold temperatures and wind 
(Francis, 1981; Sieber and Farnsworth, 1981; Shearn and Hillerton, 1996). These 
teat end lesions may represent the primary insult to the teat skin as a prelude to 
IMI. 
 
2- Soluble defenses 
Many soluble factors present in milk act in collaboration with innate and 
immune defense mechanisms. They include immunogloblulins (Ig), complement 
fractions, Lf, lysozyme and lactoperoxidase. Immunoglobulins are produced by 
local plasma cells or selectively transported from serum (Sordillo and Nickerson, 
1988b). The concentration of Ig in mammary secretions is dependent upon the 
stage of lactation, the degree of permeability of secretory tissue and the number 
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of Ig-producing cells present. In healthy mammary glands, the concentration of Ig 
is low during lactation but increases during the nonlactating period to reach peak 
concentration during colostrogenesis (Sordillo and Nickerson, 1988b). Although 
IgG1 is the predominant isotype in mammary secretions of healthy cows, 
neutrophils can transport IgG2 to the mammary gland as they emigrate towards 
the site of inflammation (Musoke et al., 1994). Immunoglobulins, together with 
complement fraction C3b, act as important opsonins that facilitate phagocytosis 
of bacteria by neutrophils during inflammation (Reiter, 1978; Howard et al., 1980; 
Targowski, 1983).  
Lactoferrin, an iron-binding glycoprotein produced by epithelial cells and 
neutrophils, is bacteriostatic by its ability to prevent growth of bacteria that have 
an iron requirement (Smith and Oliver, 1981). However, streptococci are resistant 
to the antibacterial effects of lactoferrin (Smith and Oliver, 1981; Todhunter et al., 
1985) probably because streptococci do not have a high requirement for iron 
(Weinberg, 1978). Fang and Oliver (1999) showed that different strains of S. 
uberis bound to Lf through specific lactoferrin-binding proteins. Streptococcus 
uberis may utilize Lf as a bridging molecule to adhere and later invade mammary 
epithelial cells (Fang and Oliver, 1999). 
Lysozyme is a bactericidal protein that cleaves peptidoglycans from the 
cell wall of Gram-positive bacteria as well as the outer membrane of Gram-
negative bacteria (Reiter, 1978). However, because bovine milk contains very 
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low concentrations of lysozyme (Vakil et al., 1969), the real protective role of this 
enzyme in bovine mastitis is unknown.  
Lactoperoxidase, in the presence of thiocyanate and hydrogen peroxide, 
is bacteriostatic for gram-positive bacteria such as S. aureus and streptococci 
and bactericidal for gram-negative bacteria (Outteridge and Lee, 1988). 
Lactoperoxidase is present in high concentrations in bovine milk (Reiter, 1978; 
Reiter and Harnulv, 1984). However, it is generally assumed that milk does not 
contain hydrogen peroxide (Reiter and Harnulv, 1984), and thyocianate 
concentrations may vary greatly depending on external factors such as nutrition 
(Wood, 1975); therefore, the importance of this system against mastitis causing 
pathogens is questionable. 
 
3- Cellular defenses 
Once bacteria penetrate the teat orifice, they are exposed to mammary 
gland defense mechanisms that will attempt to eliminate or control bacterial 
invasion before any serious damage is done to mammary tissue. Resident and 
newly recruited leukocytes play a key role during the initial stages of 
pathogenesis.  
 
 
 
  21 
a- Macrophages 
Macrophages are the predominant cell type found in milk from healthy 
mammary glands (Lee et al., 1980; McDonald and Anderson, 1981; Sordillo and 
Nickerson, 1988a), and are considered the first line of defense against invading 
pathogens. Macrophages have the ability of ingesting bacteria, cellular debris 
and accumulated milk components (Sordillo and Nickerson, 1988a). However, 
because of indiscriminate ingestion of fat and casein, macrophages suffer 
degranulation and loss of pseudopodia resulting in dramatically reduced 
bactericidal ability (Paape and Guidry, 1977; Reinitz et al., 1982). While 
somewhat helpless against invading bacteria, macrophages have the ability to 
release a powerful array of cytokines which play a key role in the subsequent 
inflammatory response to eliminate infection (Craven, 1983). 
An effective response requires that macrophages recognize pathogen-
associated molecular patterns that distinguish infectious agents from self, and in 
addition, discriminate among pathogens (Janeway, 1992). Two members of the 
Toll-like receptor (TLR) family play a key role in this process. TLR4 recognizes 
LPS, whereas TLR2 recognizes various fungal, gram-positive and mycobacterial 
components (Hoshino et al., 1999; Lien et al., 1999; Flo et al., 2000; Ozinsky et 
al., 2000). This family of receptors has the capacity to recognize a wide spectrum 
of stimuli, providing some specificity to the innate immune response. At least 
eight TLR have been identified (Means et al., 2000). The intracellular domains of 
TLR are similar to the intracellular domain of the interleukin-1 (IL-1) receptor, and 
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these regions are referred to as Toll/IL-1R domain. Activation of TLR triggers a 
multi-step signaling pathway which results in activation of particular target genes, 
mostly through activation of nuclear factor κB (NFκB) (O'Neil and Greene, 1998). 
This signal transduction pathway is highly similar to the one activated by IL-1 
(O'Neil and Greene, 1998). Although likely present, no reports exist on the 
presence of TLR on bovine mammary gland macrophages. 
Additionally, mammary gland macrophages are important antigen 
processing and presenting cells (Politis et al., 1992). Bacterial antigens are 
processed within macrophages and presented on the cell surface together with 
major histocompatibility complex (MHC) class II molecules. This alignment allows 
specific lymphocytes to recognize a particular antigen and mount a specific 
immune response towards it. However, Politis et al. (1992) showed that 
mammary gland macrophages are less efficient than blood monocytes in 
cytokine production, antigen presentation and antigen-specific T-cell proliferation. 
Furthermore, Politis et al. (1992) demonstrated that this inferior ability was not 
due to suppressive activity of these cells but to an overall decreased 
functionality. In contrast, Sordillo et al. (1995) reported that mammary gland 
macrophages have an enhanced ability to produce tumor necrosis factor-α (TNF-
α) when compared to blood monocytes during the periparturient period, so it is 
not that mammary gland macrophages are hyporesponsive altogether. It seems 
evident that mammary gland macrophages show functional differences 
compared with blood monocytes. Furthermore, studies by Politis et al. (1992) and 
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Sordillo et al. (1995) were conducted with two different stimulatory agents for 
macrophages. It could be possible that macrophages elicit distinct responses to 
different etiological agents of mastitis. 
 
b- Neutrophils 
Polymorphonuclear leukocytes (PMN) or neutrophils generally constitute 
less than 20% of the cells present in milk from healthy mammary glands (Lee et 
al., 1980; McDonald and Anderson, 1981). However, in milk from infected 
mammary glands, neutrophils constitute >90% of total leukocytes (Paape et al., 
1981; Sordillo et al., 1987; van Werven et al., 1999). Neutrophils travel from the 
bloodstream to the site of infection by a tightly regulated migration mechanism. 
Influx of PMN into the mammary gland occurs at a low level for immune 
surveillance but increases rapidly in response to bacterial infection, where potent 
inflammatory mediators guide PMN towards the site of infection (Paape et al., 
2000). Neutrophils play a key role in defense of the mammary gland; in fact, it 
has been been shown that the severity and duration of mastitis is related critically 
to the promptness of leukocyte migration and the bactericidal activity of 
leukocytes at the site of infection (Hill, 1981; Kehrli et al., 1989). However, similar 
to macrophages, milk PMN are less phagocytic than blood PMN (Jain and 
Lasmanis, 1978). This has been attributed to ingestion of milk components such 
as fat and casein by the PMN (Russel et al., 1976; Paape and Guidry, 1977), and 
more recently, to a direct effect of diapedesis across mammary epithelium, which 
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reduced phagocytosis and oxidative burst of bovine neutrophils (Smits et al., 
1999). These factors may explain why such high numbers of PMN are required to 
prevent infection in the bovine mammary gland (Craven and Williams, 1984). 
Bovine neutrophils differ somewhat from neutrophils of other species. Like 
other species, they contain azurophilic and specific granules. The most important 
antibacterial mechanism derived from azurophilic granules is the 
myeloperoxidase-hydrogen peroxide-halide system, one of the most potent 
bactericidal mechanisms of neutrophils (Roth, 1994). A membrane-associated 
oxidase enzyme complex converts oxygen to superoxide anion, which then 
undergoes further reactions to form hydrogen peroxide, hydroxyl radical and 
singlet oxygen (Densell and Mandell, 1990). Myeloperoxidase catalyzes a 
reaction between hydrogen peroxide and halide ions (iodide, bromide, and 
chloride), resulting in halogenation and oxidation of bacterial surface components 
and generation of hypochlorous acid, aldehydes and chloramines (Roth, 1994). 
Additionally, bovine neutrophils contain a third type of granules, larger and more 
numerous than the other two classes, which contain a variety of oxygen-
independent bactericidal compounds (Gennaro et al., 1983). 
Another difference of bovine neutrophils is that they lack Fc receptors for 
IgG1 (Howard et al., 1980). Consequently, IgG1 cannot function as an opsonin for 
bovine neutrophils. PMNs have membrane receptors for the Fc component of 
IgM and IgG2 and for complement fraction C3b, which are necessary for 
mediating phagocytosis of invading bacteria. 
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Unlike most mammalian species, bovine neutrophils are not 
chemotactically attracted to N-formylated bacterial peptides (Craven, 1986), 
which are fairly unique to prokaryotic organisms. Reasons for this are unknown, 
but might be related to the important function that microbial flora play in ruminant 
digestion, and the fact that it would not be beneficial for animals to develop an 
immune response towards beneficial microbes involved in digestion (Kehrli and 
Harp, 2001). It is not known how ruminants efficiently recognize the presence of 
bacterial peptides in undesirable locations; possibly, N-formylated bacterial 
peptides are recognized by the ruminant immune system in a more modest 
manner that results in an indirect initiation of an inflammatory response (Kehrli 
and Harp, 2001). 
 
Inflammation of the mammary gland 
Native defenses of the bovine mammary gland are challenged 
continuously by environmental exposure to bacteria. Once a pathogen has 
penetrated the teat orifice, innate and adaptive immune systems will attempt to 
prevent infection before serious damage is caused to secretory tissue. The 
sequence of events that take place is characterized initially by an acute 
inflammatory reaction dominated by neutrophil recruitment into mammary 
secretion. This is evidenced initially by an increase in somatic cell count and 
appearance of abnormal milk (flakes, clots, clumps). 
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Initial signals that trigger acute inflammation in the mammary gland are 
varied and redundant. Many chemical mediators are released within hours of 
infection and include chemotactic complement fractions, prostaglandins, platelet 
activating factor, thromboxane A2 and acute phase cytokines such as IL-1, TNF-
α, and interleukin-8 (IL-8) (Giri et al., 1984; Rose et al., 1989; Shuster et al., 
1993; Shuster et al., 1997; Riollet et al., 2000). These factors are released by 
leukocytes in milk or by mammary epithelial cells in response to bacterial 
products, and play a key role in the battle between the cows defense 
mechanisms and the pathogen.  
 
1- Fundamentals of leukocyte recruitment 
The first step involved in leukocyte recruitment is the initial contact and 
loose interaction between leukocytes in the bloodstream and endothelial cells 
from post-capillary venules.  Rolling of leukocytes against the blood vessel wall is 
mediated by members of the selectin family (Zimmerman, 1992). Molecules of 
the selectin family are heavily glycosylated, single chain integral membrane 
proteins that include CD62P, CD62E (both present in endothelial cells) and 
CD62L (present in leukocytes; Table 2). Rolling of leukocytes is mediated in part 
by CD62L which binds to mucin-like glycoproteins (GlyCAM-1 and CD34) 
expressed on postcapillary endothelial cells (Robbins, 1994). CD62L is crucial for 
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Table 2. Leukocyte-endothelial adhesion molecules. 1 
 
ENDOTHELIAL 
MOLECULE 
FAMILY LEUKOCYTE 
RECEPTOR 
FAMILY DISTRIBUTION 
E-selectin (CD62E) Selectin Sialyl-Le 
glycoprotein 
Oligosaccharide Neutrophils 
T-cells 
Monocytes 
P-selectin (CD62P) Selectin Sialyl-Le 
glycoprotein 
Oligosaccharide Neutrophils 
Monocytes 
ICAM-1 Immunoglobulin LFA-1 
Mac-1 
β2 integrin All leukocytes 
VCAM-1 Immunoglobulin VLA-4 β1 integrin Lymphocytes 
Monocytes 
Basophils 
Eosinophils 
GlyCAM-1 
CD34 
Mucin-like 
glycoproteins 
L-selectin (CD62L) Selectin Neutrophils 
Lymphocytes 
Monocytes 
1From Robbins, 1994. 
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recruitment of neutrophils into inflamed tissues; it acts by slowing down 
leukocytes upon contact with its specific ligands (Butcher, 1991).  Additionally, 
during an inflammatory response, locally produced cytokines stimulate increased 
expression of CD62P and CD62E on endothelial cells, which interact with 
undefined ligands on leukocytes and further facilitate margination of leukocytes 
(von Andrian et al., 1993). Neutrophils activated by cytokines or 
chemoattractants shed CD62L (Kishimoto et al., 1989), which is a prerequisite 
step for β2- integrin mediated tight adhesion. 
Integrins are the major family of cell surface receptors that mediate 
adhesive cell to cell interactions and attachment to extracellular matrix (Hynes, 
1992; Sonnenberg, 1993). Structurally, integrins are heterodimeric glycoproteins 
made up of alpha and beta chains. The β2-integrins are mainly involved in 
leukocyte-endothelial cell contact (Table 2). The β2-integrin family consists of 
distinct α chains, CD11a, CD11b and CD11c that share a common β chain 
(CD18). Distribution of β2-integrins on leukocyte surfaces varies with cell type 
and state of activation. The most important β2-integrin involved in neutrophil 
recruitment into inflamed tissue is Mac-1 (CD11\CD18; Arnaout, 1990). It is 
predominantly found on granulocytes with some expression on macrophages and 
natural killer cells (Arnaout, 1990). Mac-1 is predominantly stored in cytoplasmic 
granules; upon cellular activation these cytoplasmic granules translocate to the 
cell surface and expression of Mac-1 increases markedly (Miller et al., 1987; 
Arnaout, 1990). In addition to their critical role in adhesion, it is likely that β2-
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integrins mediate inside-out signaling and extracellular conformational changes 
(Miller et al., 1987) with a consequent increase in integrin affinity.  
The immunoglobulin family molecules interact with β2-integrins expressed 
on leukocytes. Intracellular adhesion molecule 1 (ICAM-1) is an integral 
membrane protein that binds to Mac-1 on leukocytes (Diamond et al., 1991). 
ICAM-1 is expressed in low levels on normal endothelium; however, expression 
of ICAM-1 increases markedly on cytokine- simulated endothelial cells (Dustin et 
al., 1986). Increased expression is important for high affinity binding of 
leukocytes to postcapillary venules and subsequent migration into inflamed 
tissues (Dustin et al., 1986). 
The currently accepted model for neutrophil adhesion and transmigration 
in acute inflammation postulates the following steps (Robbins, 1994): 
• Initial rapid and relatively loose adhesion that accounts for rolling, 
involving mainly the naturally occurring CD62L and CD62P, and, in 
cytokine induced endothelium, CD62E. 
• Activation of leukocytes by agents made by endothelium or other cells 
or emanating from the site of injury, to increase avidity of integrins. 
• Strong binding of leukocytes and endothelial cells, largely through β2-
integrin-ICAM pathway, and consequent transmigration. 
Mechanisms controlling PMN transepithelial migration in the mammary gland are 
likely to be unique due to multiple roles of lactating mammary 
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epithelium. Furthermore, leukocytes must not only traverse the capillary 
endothelium but also the extracellular matrix and mammary epithelial cells in 
order to arrive to the alveolar lumen. Smits et al. (2000) investigated the role of 
Mac-1 in diapedesis across the blood-milk barrier in an in vitro model and 
reported that neutrophil migration across mammary endothelial cells was almost 
completely dependent on CD18, the β chain of β2-integrins. Neutrophil 
diapedesis across mammary epithelial cells was dependent to a greater extent 
on CD11b (Smits et al., 2000). These results provide evidence that different 
mechanisms exist for neutrophil migration across various cell layers of the blood-
milk barrier. 
 
2- Acute phase response mediators 
Upon bacterial invasion of the mammary gland, a wide array of 
inflammatory mediators is released from bacterial cells as well as from host cells 
that react to the foreign presence and give notice to the immune system in order 
to attempt to control and eliminate the infection. These inflammatory mediators 
include a variety of bacterial products; as well as prostaglandins; leukotrienes; 
histamine; complement fractions; and acute phase cytokines such as IL-1, TNF-
α, interleukin-6 (IL-6), interleukin-8 (IL-8) and several colony stimulating factors 
(Giri et al., 1984; Rose et al., 1989; Shuster et al., 1993; Riollet et al., 2000). 
These bioactive products have varied effects on local tissues and also direct 
leukocyte migration into inflamed tissues. Additionally, they exert systemic effects 
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such as fever, breakdown of the blood-milk barrier and increased bone marrow 
output of leukocytes to replenish supplies in the bloodstream.  
 
a- Tumor necrosis factor-α 
Tumor necrosis factor-α is the principal mediator of the response to gram-
negative bacteria (Shuster et al., 1993; Riollet et al., 2000) and may also play a 
role in innate immune responses to other infectious agents (van den Berg et al., 
1999; Malazdrewich et al., 2001). Newly synthesized pro-TNF-α is first displayed 
on the plasma membrane and then proteolytically cleaved in the extracellular 
domain to release the mature TNF-α (Kriegler et al., 1988). The 17-kDa soluble 
TNF-α is the mature form mediating biologic effects. The 26-kDa transmembrane 
pro-TNF-α, however, is also active and has been shown to mediate the cytotoxic 
effect of TNF-α through cell-to-cell contact (Kriegler et al., 1988).  
Tumor necrosis factor-α synthesis can be stimulated in various cell types 
by a wide range of stimuli. Although produced predominantly by monocyte-
macrophages, TNF-α is also made by other cells such as fibroblasts, epithelial 
cells, mast cells, neutrophils, natural killer cells and many others (Wang and 
Tracey, 1999). Exogenous and endogenous factors produced by bacteria, 
viruses, parasites and tumors are capable of inducing cells to produce TNF-α 
(Wang and Tracey, 1999). Lipopolysaccharide (LPS) is the classical inductor of 
TNF-α synthesis in monocytes and macrophages through CD14, a specific LPS 
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receptor (Wright et al., 1990). Paape et al. (1996) reported the presence of  
CD14 on bovine mammary PMN and macrophages.  
The activity of TNF-α is mediated through at least two types of cell surface 
receptors, type I (TNFRI) and type II (TNFRII), which are present on virtually all 
cell types (Hohmann et al., 1989). Most biologic activities of TNF-α are mediated 
through TNFRI (Espevik et al., 1990), and involve increased rates of transcription 
of particular target genes, often through activation of NFκB or AP-1 transcription 
factors (Malinin et al., 1997). 
When small quantities of TNF-α are produced, TNF-α acts locally as a 
paracrine and autocrine regulator of leukocytes and endothelial cells. Principal 
biological activities of TNF-α include activation of endothelial cells in the 
vasculature to express new adhesion molecules that will facilitate neutrophil and 
subsequently monocyte and lymphocyte migration. Additionally, TNF-α 
stimulates macrophages and other cell types to secrete chemokines that 
contribute to leukocyte recruitment, and also activates leukocytes to kill invading 
microbes (Abbas et al., 1997). 
When larger amounts of TNF-α are produced, TNF-α can enter the 
circulation and have systemic effects. These include induction of fever by 
increased synthesis of prostaglandins in the hypothalamus, stimulation of 
macrophages and perhaps vascular endothelial cells to stimulate secretion of IL-
1 and IL-6, and stimulation of hepatocyte synthesis of acute phase proteins 
(Baumann and Gauldie, 1994).  
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The role of TNF-α as an inflammatory mediator during mastitis has been 
studied extensively in E. coli and endotoxin induced mastitis (Shuster et al., 
1993; Shuster et al., 1996; Rainard and Paape, 1997; Blum et al., 2000; Riollet et 
al., 2000; Paape et al., 2002). As a general rule, after E. coli or endotoxin 
challenge, TNF-α concentrations increase sharply in the inflamed mammary 
gland, peaking within 24 hours of initial challenge and decreasing sharply 
afterwards (Shuster et al., 1997; Riollet et al., 2000; Paape et al., 2002). 
Increased TNF-α  concentration in infected mammary glands also correlates with 
enhanced leukocyte migration from the bloodstream into the mammary gland and 
with the onset of clinical signs of mastitis (Blum et al., 2000; Paape et al., 2002). 
TNF-α  is clearly associated with acute inflammation, but was not detected in 
milk of cows with chronic S. aureus mastitis (Riollet et al., 2000). 
The role of TNF-α during S. uberis mastitis has not been investigated. 
Although different S. uberis strains have shown different pathogenicity (Hill, 
1988; Oliver, personal communication), S. uberis mastitis tends to be less severe 
than E. coli mastitis, although it can cause serious clinical infections. 
Furthermore, S. uberis mastitis can be of long duration as opposed to E. coli 
mastitis, which is usually eliminated by the animal within 5 to 6 days (Hill et al., 
1978; Lohuis et al., 1990; Shuster et al., 1996; Shuster et al., 1997).   
Streptococcus uberis, as a gram-positive organism, is markedly different 
from E. coli, and its antigenic determinants and virulence factors may likely elicit 
different effector mechanisms of the inflammatory response. A study by Tissi et 
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al. (1999) evaluated the role of TNF-α and other cytokines in a mouse model of 
group B streptococcal arthritis. Interestingly, Tissi et al. (1999) found that TNF-α 
was not detected in joints of mice injected with group B Streptococcus throughout 
the challenge period, even when articular lesions were most frequent and severe. 
These findings suggest that TNF-α is not involved in the pathogenesis of 
streptococcal arthritis. It is possible that other streptococci such as S. uberis 
stimulate similar inflammatory responses. 
 
b- Interleukin-1 
Interleukin-1 is the prototype multifunctional cytokine, affecting nearly 
every cell type, often in concert with TNF-α (Dinarello, 1999). The primary source 
of IL-1 is the activated macrophage; however, many other cell types such as 
epithelial cells and endothelial cells can produce IL-1. Specifically for the 
mammary gland, it has been demonstrated that mammary epithelial cells can 
produce IL-1 upon LPS stimulation (Boudjellab et al., 2000), and probably upon 
other stimuli. There are two forms of IL-1, referred to as IL-1α and IL-1β, but their 
biological activity is identical. Most of the IL-1 activity found in the circulation is 
IL-1β (Abbas et al., 1997). Two different membrane receptors have been 
characterized for IL-1, both of which belong to the Ig superfamily, referred to as 
type I and type II receptors. The type I receptor has slightly higher affinity for IL-
1β, and mediates most of the IL-1 responses (Sims et al., 1993). 
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When produced in low amounts, IL-1 acts locally on endothelial cells to 
promote coagulation and to increase expression of surface molecules that 
mediate leukocyte adhesion. Interleukin-1 does not directly activate leukocytes, 
but causes macrophages and endothelial cells to synthesize chemokines that do 
activate leukocytes, such as IL-6. When secreted into the circulation, IL-1 shares 
with TNF-α the ability to cause fever, induce hepatic synthesis of acute phase 
proteins and initiate metabolic wasting (Abbas et al., 1997).  
The dynamics of IL-1 production have also been studied in detail during E. 
coli and endotoxin mastitis (Shuster et al., 1993; Shuster et al., 1996; Shuster et 
al., 1997; Riollet et al., 2000). Interleukin-1 concentrations increased sharply and 
usually peaked shortly after TNF-α concentrations (Shuster et al., 1997; Riollet et 
al., 2000). Similarly to TNF-α, no information exists on IL-1 production during S. 
uberis mastitis.  
 
c- Interleukin-8 
Interleukin-8 belongs to the chemokine family of cytokines.  Chemokines 
are small molecules, approximately 8 to 10 kDa in size, characterized by their 
strong chemotactic ability (Oppenheim et al., 1991; Baggiolini et al., 1994). 
Interleukin-8 has been established as a principal chemotactic factor directing 
neutrophil recruitment to and activation at the inflammatory focus (Harda et al., 
1994). Activated monocytes and macrophages appear to be the predominant 
cellular sources of IL-8, but several nonimmune cells, such as epithelial cells can 
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also produce this chemokine (Eckmann et al., 1993). Recently, Boukjellab et al. 
(1998) reported IL-8 production by bovine mammary epithelial cells following LPS 
stimulation. Barber and Yang (1998) indicated presence of IL-8 in mammary 
secretions from cows with mastitis and reported that the chemotactic ability of 
those secretions was due to IL-8. 
Interleukin-8 is expressed at high levels in milk from cows with coliform 
mastitis (Riollet et al., 2000). Interleukin-8 production begins more slowly than 
TNF-α and IL-1 and persists longer (Shuster et al., 1997; Riollet et al., 2000). 
Barber and Yang (1998) detected IL-8 activity in mammary secretions from a cow 
clinically infected with S. aureus. The role of IL-8 during S. uberis mastitis, 
however, has not been determined. 
 
SUMMARY AND STATEMENT OF THE PROBLEM 
 
Bovine mastitis is the most common and expensive disease affecting dairy 
cows throughout the world. Studies have shown that as the prevalence of 
contagious mastitis pathogens was reduced, the proportion of IMI by 
environmental mastitis pathogens increased markedly. Streptococcus uberis is 
an environmental pathogen that accounts for a significant proportion of clinical 
and subclinical mammary gland infections worldwide and is not readily controlled 
by current mastitis control measures. The pathogenesis of S. uberis mastitis is 
incompletely understood. Most pathogenesis studies on bovine mastitis have 
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been conducted using E. coli or endotoxin experimental challenge models; these 
studies have elucidated the role of blood and milk leukocytes as well as several 
acute phase inflammatory mediators in the development of E. coli mastitis. No 
information exists on the role of inflammatory mediators during S. uberis 
infection. Therefore, the objective of this study is to evaluate the dynamics of 
leukocytes and cytokines during experimentally induced S. uberis mastitis. A 
better understanding of the pathogenesis of S. uberis mastitis will facilitate 
development of more efficient control strategies that will minimize economic 
losses and improve animal health and milk quality. 
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Chapter 3 
DYNAMICS OF LEUKOCYTES AND CYTOKINES DURING 
EXPERIMENTALLY-INDUCED STREPTOCOCCUS UBERIS 
MASTITIS 
 
INTRODUCTION 
 
Bovine mastitis continues to be the most economically devastating 
disease affecting the dairy industry (National Mastitis Council, 1996). Of the 
many bacterial pathogens capable of causing mastitis, environmental pathogens 
have become increasingly problematic, particularly in herds that have 
successfully controlled contagious pathogens (Oliver and Mitchell, 1984; Oliver, 
1988; Todhunter et al., 1995). Among environmental pathogens, Streptococcus 
uberis is one of the most prevalent, accounting for a significant proportion of 
subclinical and clinical intramammary infections (IMI) in both lactating and 
nonlactating cows (Smith et al., 1985; Oliver, 1988; Todhunter et al., 1995; 
Jayarao et al., 1999; Phuektes et al., 2001). 
Acceptance and widespread application of mastitis control practices 
devised in the 1960s has led to considerable progress in the control of 
contagious mastitis pathogens. However, these procedures have been less 
effective against environmental mastitis pathogens. One possible approach to 
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controlling environmental mastitis involves manipulation of host defense 
mechanisms. This approach requires knowledge of host and pathogen factors 
involved in the development and establishment of IMI as well as defense 
mechanisms within the udder and ways to enhance these mechanisms (Calvinho 
et al., 1998). However, the pathogenesis of S. uberis mastitis is incompletely 
understood. The role of polymorphonuclear neutrophils (PMN) has been well 
established in the defense against Escherichia coli (Hill et al., 1978) and 
Staphylococcus aureus infection of the bovine mammary gland (Schalm et al., 
1976). This has not been established for the control of IMI by S. uberis. 
Furthermore, to our knowledge, a description of inflammatory mediator 
production during S. uberis mastitis does not exist in the literature. The role of 
cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and 
interleukin-8 (IL-8) have been studied extensively during E. coli and endotoxin-
induced mastitis (Shuster et al., 1993; Shuster et al., 1996; Rainard and Paape, 
1997; Blum et al., 2000; Riollet et al., 2000; Paape et al., 2002). No information 
exists on the role of cytokines during S. uberis mastitis. Streptococcus uberis, a 
prevalent gram-positive mastitis pathogen, is markedly different from E. coli, and 
its antigenic determinants and virulence factors likely elicit different effector 
mechanisms of the inflammatory response. To gain a better understanding of the 
pathogenesis of S. uberis mastitis, the objective of the present study was to 
evaluate the dynamics of leukocytes and cytokines, if produced, during 
experimentally induced S. uberis mastitis. 
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MATERIALS AND METHODS 
 
Experimental herds 
Lactating cows from two dairy research herds of The University of 
Tennessee were used in this study. The Dairy Experiment Station (DES) 
research herd in Lewisburg, TN consists of approximately 170 lactating Jersey 
cows. The herd is Streptococcus agalactiae-negative and has a low prevalence 
of S. aureus but experiences mastitis problems caused by environmental 
pathogens, in particular S. uberis, Streptococcus dysgalactiae subsp. 
dysgalactiae and Gram-negative bacteria. Cows in the DES research herd are 
milked twice daily in a 12-stall trigon milking parlor equipped with automatic 
milking machine take-offs (Surge, Babson Bros., Oak Brook, IL, USA). Milking 
machines are backflushed (Surge Backflush II, Babson Bros.) with water after 
removal from cows. Premilking and postmilking teat disinfection are practiced. 
Animals are fed rations consistent with stage of lactation and described in the 
standard operating procedures of the site. Water is provided ad libitum. Lactating 
cows are housed in free stalls at ambient temperature. Stalls are bedded with 
dairy waste solids separated from a manure slurry (Alfa-Laval, Inc., Kansas City, 
MO, USA). Cows are pastured 4 to 6 hours per day when weather and pasture 
permit. Bovine somatotropin (Posilac, Monanto, St. Louis, MO, USA) is used as a 
management tool to increase milk production of lactating dairy cows after peak 
lactation. All cows are dried off approximately 6 to 8 weeks before expected 
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calving and all mammary glands of cows are infused with an antibiotic 
preparation approved for use in nonlactating cows following the last milking of 
lactation. 
The Middle Tennessee Experiment Station (MTES) dairy research herd in 
Spring Hill, TN is composed of approximately 150 lactating Holstein cows. The 
herd is S. agalactiae-negative but experiences mastitis problems caused 
by S. aureus and environmental pathogens, in particular S. uberis. Cows 
in the MTES dairy research herd are milked twice daily in a double-eight 
parallel parlor equipped with a DeLaval milking machine system (De 
Laval) with automatic milking machine take-offs. Premilking- and postmilking teat 
disinfection are practiced. Milking equipment is evaluated routinely and 
maintained per manufacturer's recommendation. Animals are fed rations 
consistent with stage of lactation and as described in the standard operating 
procedures of the site. Water is provided ad libitum. Lactating cows are housed 
in free stalls at ambient temperature. Stalls are bedded with 
sawdust. Lactating cows are allowed on pasture for exercise for 4 hours per 
day when weather permits. Bovine somatotropin (Posilac, Monanto) is used as 
a management tool to increase milk production of lactating dairy cows after 
peak lactation. All cows are dried off approximately six to eight weeks 
before expected calving and all mammary glands of cows are infused with 
antibiotic preparations approved for use in nonlactating following the last milking 
of lactation. 
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Animals 
Five clinically healthy Holstein cows from the Middle Tennessee Dairy 
Experiment Station and 5 clinically healthy Jersey cows from the Dairy 
Experiment Station were used in this experiment. All cows were approximately 
11-38 days in milk, in their 2nd lactation, and had not been exposed previously to 
S. uberis. Each cow was challenged by intramammary inoculation in 2 uninfected 
mammary glands. One non-challenged mammary gland from each cow served 
as a within-cow negative control. Selection of uninfected mammary glands for the 
experiment was based on microbiological examination of mammary secretions 
14 and 7 days prior to challenge and SCC of <2.5 X 105 cells/ml. 
 
Bacterial suspension and challenge exposure 
Streptococcus uberis UT888, isolated originally from a cow with clinical 
mastitis, was used in the experimental challenge study. Stock bacterial cultures 
stored at 80°C were thawed, plated on a trypticase soy agar plate 
supplemented with 5% defibrinated sheep blood (Beckton Dickinson 
Microbiology Systems, Cockeysville MD, USA), and incubated overnight at 37ºC 
in a 5% CO2 incubator. Approximately two to five colonies were then subcultured 
at 37°C in Todd Hewitt Broth (Difco, Detroit, MI, USA) for 7 hours to a 
concentration of approximately 5X108 colony forming units (CFU)/ml. Bacterial 
cultures were then diluted in sterile phosphate-buffered saline (PBS). 
  43 
Inoculation procedure 
Within 0.5 hours after the afternoon milking, teats of cows were cleaned 
thoroughly with individual disposable paper towels, and teat ends sanitized with 
swabs containing isopropyl alcohol. The bacterial suspension was infused using 
sterile disposable syringes fitted with sterile disposable teat cannulas. Five ml of 
inoculum containing 6,650 CFU (Jersey cows) or 10,500 CFU (Holstein cows) of 
S. uberis in sterile PBS were infused into two uninfected mammary glands of 
each cow. The infused inoculum was massaged upward into the gland cistern. 
Teats were immersed in a postmilking teat disinfectant when the above 
procedure had been completed. The actual number of bacteria infused into 
mammary glands was determined by viable plate count on blood agar before and 
after inoculation. 
 
Milk sampling regimen 
Milk samples were collected at 0, 12, 18, 24, 36, 42, 48, 60, 66, 72, 84, 90, 96, 
108, 114, 120, 144 and 168 hours after challenge (Table 3). When the sampling 
time point coincided with milking, samples were collected before cows were 
milked. Samples of foremilk for microbiological examination were collected 
aseptically as described by Oliver et al. (1994). Before sample collection, teats of 
cows were cleaned thoroughly with individual disposable paper towels, and teat 
ends were sanitized with swabs containing isopropyl alcohol. Samples were 
collected in sterile tubes and stored at 20ºC until analysis. Samples for 
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Table 3. Sampling schedule for cows challenged with Streptococcus uberis. 
 
 
Hours Micro1 SCC2 
(challenged 
mammary 
glands) 
SCC2 
(control 
mammary 
glands) 
Cytokines3 
(challenged 
mammary 
glands) 
Cytokines3 
(control 
mammary 
glands) 
Evaluation 
of animals4 
Blood 
0 X X X X X X X 
12 X X  X  X X 
18 X X  X   X 
24 X X X X X X X 
36 X X  X  X X 
42 X X  X   X 
48 X X X X X X X 
60 X X  X  X X 
66 X X  X   X 
72 X X X X X X X 
84 X X  X  X X 
90 X X  X   X 
96 X X X X X X X 
108 X X  X  X X 
114 X X  X   X 
120 X X X X X X X 
144 X X X X X X X 
168 X X X X X X X 
 
1Milk for microbiological analysis, all mammary glands sampled. 
2Milk for determination of the number of somatic cells. 
3Milk for cytokine analysis. 
4Rectal temperature, physical palpation of the udder and strip cup examination of mammary secretions. 
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determination of numbers of somatic cells (approximately 30 ml) were collected 
in plastic snap cap vials (Capitol Vial Co.) preloaded with Bronopopl-B as 
preservative. Samples for determination of numbers of somatic cells were 
shipped via overnight courier to the Dairy Herd Improvement Association (DHIA) 
Laboratory, The University of Tennessee, Knoxville, TN, for analysis. Milk 
samples for cytokine quantification (50 ml) were collected in sterile 50 ml plastic 
tubes. Samples were refrigerated at 4ºC immediately after collection, shipped via 
overnight courier and whey was obtained as described below upon arrival to the 
Lactation/Mastitis Laboratory at The University of Tennessee, Knoxville, TN. 
 
Evaluation of animals 
Clinical assessment of all animals was performed before experimental 
challenge and at 0, 12, 18, 24, 36, 42, 48, 60, 66, 72, 84, 90, 96, 108, 114, 120, 
144 and 168 hours after challenge. Rectal temperatures were determined at 
similar time points. Clinical status of all mammary glands and appearance of milk 
was evaluated using the following scheme: 
Milk: 1= normal, 2= a few flakes, 3= small slugs, 4= large slugs/clots, 5= 
stringy/watery, and 6= bloody. 
Udder: 1= normal, 2=slight swelling, 3= moderate swelling, 4= severe 
swelling, 5= scar tissue, and 6= edema. 
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Cows that developed clinical mastitis (defined as visible abnormalities in 
the mammary gland and/or milk) were monitored closely and antibiotic treatment 
was initiated after day 7 post-challenge or earlier if required. An IMI was defined 
as a challenged mammary gland where S. uberis was isolated at 2 or more 
occasions during the one week experimental period. 
 
Determination of numbers of somatic cells in milk 
Numbers of somatic cells in milk for each challenged and control 
mammary gland were determined by DHIA personnel at The University of 
Tennessee, Knoxville, TN, with a Somacount 300 cell counter (Bentley 
Instruments, Chaska, MN, USA). 
 
Bacteriological examination of mammary gland foremilk samples 
Milk samples were examined following procedures recommended by the 
National Mastitis Council and essentially as described by Oliver et al. (1994). 
Thawed samples of mammary secretion were mixed thoroughly by vortexing, and 
10 µl of each sample were spread onto one quadrant of a trypticase soy agar 
plate supplemented with 5% defibrinated sheep blood (Beckton Dickinson 
Microbiology Systems). Plates were incubated at 37ºC and bacterial growth was 
observed and recorded at 24-h intervals for three days. Bacteria were identified 
tentatively according to colony morphologic features, hemolytic characteristics, 
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and catalase test. Isolates identified presumptively as staphylococci were tested 
for coagulase by the tube coagulase method. Isolates identified presumptively as 
streptococci were evaluated initially for growth in 6.5% NaCl, hydrolysis of 
esculin and CAMP reaction. Streptococcal organisms were identified to the 
species level using the API 20 Strep System (bioMerieux, Vitek Inc., Hazelwood, 
MO, USA) upon first and last isolation of the organism from experimentally 
infected mammary glands. Streptococcal organisms isolated between the first 
and last isolation were identified as S. uberis by growth in 6.5% NaCl, hydrolysis 
of esculin and CAMP reaction. When necessary, milk samples were diluted in 
PBS and four-10 µl drops of each dilution were plated on trypticase soy agar to 
determine the number of S. uberis per ml of milk. 
 
Preparation of whey samples 
Whole milk samples from challenged and control mammary glands of 
cows in the MTES herd were centrifuged at 48,000 x g for 40 minutes at 4ºC. 
Whey was harvested between the supernatant (fat layer) and the infranatant 
(casein and cells). Milk samples from cows in the DES herd were centrifuged at 
27,000 x g for 30 minutes at 4ºC, the fat layer was removed and the sample pH 
was decreased to 4.5 by addition of glacial acetic acid. Samples were centrifuged 
at 27,000 x g for 30 minutes at 4ºC to precipitate casein and the supernatant was 
removed by filtration through gauze sponges. The pH was restored to 6.5-7.5 
immediately before cytokine analysis by addition of NaOH. All samples were 
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stored at 80ºC until cytokine analysis by enzyme-linked immunosorbent assay 
(ELISA).  
 
IL-1β ELISA 
Bovine IL-1β was measured by ELISA using commercial antibodies 
against ovine IL-1β (Serotec Inc., Raleigh, NC, USA), with the coating 
monoclonal antibody and the detecting antiserum diluted as suggested by the 
manufacturer. Flat bottom 96-well plates (Corning Inc., Corning, NY, USA) were 
coated with 100 µl of monoclonal antibody anti-ovine IL-1β at a concentration of 5 
µg/ml diluted in PBS and incubated at 4ºC overnight. Plates were washed three 
times with PBS-0.01% Tween (PBST), and 200 µl of 5% bovine serum albumin 
(BSA) in PBST were added to each well to block nonspecific protein binding 
sites. Plates were incubated for 1 hour at 37ºC. After washing plates as before, 
100 µl of whey were loaded into each well, together with serial 2-fold dilutions of 
purified rbIL-1β (10 ng/ml to 0.31 ng/ml) for use as a standard (generously 
provided by Susan Dunney, Fort Dodge Animal Health, Princeton, NJ, USA). 
After incubation for 1 hour at 37ºC, plates were washed 3 times and 100 µl of 
rabbit anti-ovine IL-1β diluted 1:500 in PBST-1%BSA were added to each well. 
Plates were incubated for 1 hour at 37ºC, washed 3 times and 100 µl of goat 
anti-rabbit IgG conjugated with horseradish peroxidase (Jackson 
Immunoresearch, West Grove, PA, USA) diluted 1:20000 in PBST-1%BSA were 
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added to each well. Plates were incubated for 1 hour at 37ºC, washed 3 times 
and 100 µl of the enzyme substrate, 52 mM 2,2-azino-bis-(3-etylbenzthiazoline-
6-sulfonic acid) (Sigma, St. Louis, MO, USA) in 0.1M citrate buffer (pH 4.2) with 
0.075% hydrogen peroxide were added to each well. Absorbance was read at 
405 nm with an ELISA plate reader (Bio-Tek, Winooski, VT, USA) after about 30 
minutes at room temperature. Wells that received normal pooled whey from 
uninfected mammary glands served as blanks. Bovine IL-1β concentrations were 
calculated by referring to a standard curve. All samples were assayed in 
triplicate. 
 
 TNF-α ELISA 
Concentrations of TNF-α in whey were quantified as described by Paape 
et al. (2002) with slight modifications. Wells were coated with 100 µl of 
monoclonal antibody anti-bovine TNF-α (2C4 1D3, generously provided by Dr. 
Max Paape, ARS, USDA, Beltsville, MD, USA) diluted 1:1000 in carbonate-
bicarbonate buffer (pH 9.6). After incubation overnight at 4ºC, plates were 
washed 3 times with PBST and 200 µl of PBS-1%BSA were added to each well 
to block nonspecific protein binding sites. Plates were incubated for 1 hour at 
37ºC in a humidified chamber. After washing as before, 100 µl of appropriate 
dilutions of samples to be tested were added to each well and incubated at 37ºC 
for 2 hours. Plates were then washed 3 times and 100 µl of rabbit serum anti-
TNF-α (generously provided by Dr. Ted Elsasser, ARS, USDA, Beltsville, MD, 
  50 
USA) diluted 1:5000 in PBST-1%BSA were added to each well. Plates were 
incubated for 2 hours at 37ºC in a humidified chamber. After washing the plates 
as before, 100 µl of goat anti-rabbit IgG conjugated with horseradish peroxidase 
(Jackson Immunoresearch) diluted 1:20000 in PBST-1%BSA were added to 
each well and incubated for 2 hours at 37ºC in a humidified chamber.  
Horseradish peroxidase activity was detected by addition of the enzyme 
substrate, 52 mM 2,2-azino-bis-(3-etylbenzthiazoline-6-sulfonic acid; Sigma) in 
0.1M citrate buffer (pH 4.2) with 0.075% hydrogen peroxide to each well. 
Absorbance was read at 405 nm with an ELISA plate reader (Bio-Tek) after 
about 30 minutes at room temperature. Wells that received normal pooled whey 
from uninfected mammary glands served as blanks. Two-fold dilutions of cell 
culture supernatant from LPS stimulated monocytes with a known concentration 
of TNF-α were used to establish a standard curve. All samples were assayed in 
triplicate. 
 
IL-8 ELISA 
Concentrations of IL-8 in whey were measured by use of a commercial 
ELISA kit (R&D Systems, Minneapolis, MN, USA) essentially as described by the 
manufacturer. Fifty microliters of standard containing known amounts of 
recombinant human IL-8 (rhIL-8) or samples were added in duplicate to wells 
precoated with monoclonal antibody against rhIL-8. A polyclonal antibody anti-
rhIL-8 conjugated with horseradish peroxidase was also added to wells. Samples 
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were incubated for 3 hours at room temperature, washed 6 times and 200 µl of 
the enzyme substrate tetramethylbenzidine were added to wells. Samples were 
incubated for 30 minutes at room temperature in the dark, and the enzymatic 
reaction was stopped by addition of 2N sulfuric acid. The optical density at 
450/562 nm was determined with an ELISA plate reader (Bio-Tek). The IL-8 
concentration in samples was determined by comparing absorbance obtained 
with that of the standard curve. 
 
Blood samples 
Blood was collected in Holstein cows only. Blood samples for leukocyte 
total counts and adhesion molecule expression were collected in vacutainer 
tubes containing 2X Acid Citrate Dextrose (ACD, pH 6.1) in a 20% vol/vol as 
anticoagulant by puncture of the tail vein. Samples were collected immediately 
prior to bacterial challenge and at the same time milk samples were taken. Blood 
was shipped via overnight courier and processed immediately upon arrival at the 
laboratory. 
 
Leukocyte counts of whole blood 
Total leukocyte counts on blood were determined manually with a 
hemocytometer after lysing erythrocytes with a Unopette microcollection system  
kit (Beckton Dickinson and Co., Franklin Lanes, NJ, USA).  
  52 
Neutrophil isolation 
Neutrophils were isolated as described previously (Aarestrup et al., 1994) 
with some modifications. Blood was centrifuged at 860 x g for 30 minutes at 
15ºC, and the plasma and buffy coat were discarded. Neutrophils were isolated 
from the remaining erythrocytes by adding an equal volume of double-distilled 
water for 30 seconds and then by adding a 3X concentration of RPMI 1640 
medium (Sigma) to regain isotonicity of the solution. Remaining cells were 
washed twice with Hanks balanced salt solution (Sigma) and resuspended in 
FACS solution (0.15M PBS, pH 7.2; 2% heat inactivated fetal bovine serum; 
0.03% sodium azide) to a final concentration of 107 cells/ml. 
 
Neutrophil adhesion molecule expression 
Indirect immunofluorescent analysis of β2 integrin expression on 
neutrophils in blood samples was performed by measuring CD18 and CD11b 
expression using murine monoclonal antibodies and fluorescein-conjugated 
antibody to mouse IgG. Additionally, expression of selectin CD62 on neutrophils 
was evaluated. Fifty microliters of neutrophil suspension were added to 96-well 
round bottom microtitre plates with 50 µl of FACS solution (negative control), 
monoclonal antibodies to bovine CD11b (BAQ147A, VMRD Inc., Pullman, WA, 
USA), bovine CD18 (BAQ30A, VMRD Inc.) or bovine L-selectin (DU1-29, VMRD 
Inc.). Plates were incubated at 4ºC for 30 minutes, washed 3 times with FACS 
solution, and 100 µl of goat anti-mouse IgG fluorescein conjugate (Calbiochem, 
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La Jolla, CA, USA) were added to each well. Samples were incubated at 4ºC for 
30 minutes, washed as before, and resuspended in 2% formaldehyde in 0.15M 
PBS. Samples were stored at 4ºC in the dark until assayed by flow cytometry. 
 
Flow cytometry analysis 
Fluorescence was measured with a FACScan flow cytometer (Beckton 
Dickinson Immunocytommetry Systems, San Jose, CA, USA). Dot plots were 
gated for PMN. Leukocytes were assayed for size by forward scattering and for 
granularity by side scattering. Expression of cell adhesion molecules (i.e., mean 
fluorescence intensity (MFI)) was calculated after plotting fluorescence of  
histograms. Fluorescence associated with PMN incubated with FITC-goat anti-
mouse IgG secondary antibody in the absence of anti-CD18 or anti-CD11b was 
considered the control for nonspecific fluorescence. Data were expressed as 
relative fluorescence intensity units after subtraction of nonspecific (control) 
fluorescence. 
 
Statistical analysis 
Analysis of variance was done with mixed models using SAS software 
(SAS 8.02, SAS Institute Inc, Cary, NC). A randomized block design with 
replication was used to determine effect of infection with S. uberis over time. 
When necessary, data were converted to log10 to maintain a normal distribution 
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for statistical analysis. Data are presented as least square means with 
associated standard error. Statistical significance was declared at P<0.05, and a 
trend toward significance was declared at P<0.10.  
 
RESULTS 
 
Experimental challenge and infection with Streptococcus uberis 
Five Holstein cows and 5 Jersey cows were challenged with S. uberis in 2 
uninfected mammary glands. Seven cows became infected in both challenged 
mammary glands, 2 cows became infected in 1 of 2 challenged mammary 
glands, and 1 cow did not become infected in either challenged mammary gland. 
There were no significant differences between breeds in response to challenge 
with S. uberis for all parameters evaluated (P>0.05). Therefore, data from all 
cows were combined for subsequent analysis. 
  
Clinical signs 
Following bacterial challenge with S. uberis, 16 of 20 challenged 
mammary glands developed clinical mastitis. Significant changes in mammary 
and milk scores were first observed at 84 hours after challenge and peaked at 
144 hours after challenge (P<0.01; Table 4). Infected mammary glands exhibited 
swelling and mammary secretions were obviously abnormal, with presence of 
clots and slugs. Local symptoms were accompanied by a mild systemic 
  
Table 4. Clinical signs in cows challenged with Streptococcus uberis. 
 
 
Hours  
0 12 18 24 36 42 48 60 66 72 84 90 96 108 114 120 144 168 SE4 
Temperature (ºC)                   
CI1 (n=9) 38.7 38.6 38.7 39.3 38.9 38.5 39.1 38.7 38.6 39.2 39.2 39.0 39.7 39.4 38.9 39.3 38.3 38.3 0.3 
CU2 (n=1) 38.6 38.9 38.5 39.2 39.1 39.6 39.5 38.9 38.9 38.8 38.1 38.0 38.4 38.8 38.2 38.6 38.8 38.4  
Mammary score                   
CI (n=16) 1a 1 a  1 a 1 a  1.19a 1.19a  1.5 a 1.69 b  2.44 b 2.63 b  3.0 b 3.13 b 2.88 b 0.18 
CU (n=4) 1 1  1 1  1 1  1 1  1 1  1 1 1  
Control3 (n=9) 1 1  1 1  1 1  1 1  1 1  1 1 1  
Milk score                   
CI (n=16) 1a 1a  1a 1a  1a 1.13a  1.56a 2.06b  2.18b 2.63b  2.5b 3.63b 3.13b 0.21 
CU (n=4) 1 1  1 1  1 1  1 1  1 1  1 1 1  
Control (n=9) 1 1  1 1  1 1  1 1  1 1  1 1 1  
 
1Challenged infected mammary glands. 
2Challenged uninfected mammary glands. 
3Control unchallenged mammary glands. 
4SE= standard error of the mean. 
a,b,cValues within the same row with different superscript differ (P<0.01). 
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response, evidenced by an increase in rectal temperature in all infected cows. 
Rectal temperatures did not peak at a similar time point in all cows. Mean 
maximum rectal temperature was 40.7±0.3ºC. Unchallenged control mammary 
glands and 4 challenged mammary glands did not become infected and did not 
exhibit clinical signs. Based on severity of clinical signs, 3 mammary glands  
received antimicrobial therapy at 120 hours, 8 mammary glands received 
antimicrobial therapy at 144 hours and 4 mammary glands received antimicrobial 
therapy 168 hours after challenge. 
 
Enumeration of bacteria and somatic cells 
For the first 42 hours after intramammary inoculation, S. uberis was found 
in very low numbers in challenged infected mammary glands (Figure 1). Since 
Holstein cows received a slightly higher inoculum dose than Jersey cows, S. 
uberis was isolated at earlier time points in Holstein cows (Table 5). However, 
bacterial numbers in those isolations were very small (Appendix). Numbers of S. 
uberis in milk increased significantly (P<0.05; Figure 1) by 48 hours after 
challenge. Between 48 hours and 120 hours after challenge, the time point at 
which maximal bacterial concentration was reached (5.03 log10±0.79 CFU/ml; 
P<0.01), numbers of S. uberis in mammary secretions increased 1,500-fold. This 
occurred in spite of massive leukocyte infiltration from the bloodstream into 
challenged mammary glands (Figure 2). Significant increases in bacterial 
numbers coincided with appearance of clinical signs (Table 4). After reaching a 
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Figure 1. Enumeration of Streptococcus uberis in milk (CFU/ml (log10)) from 
mammary glands of cows challenged with S. uberis. Data are means ± SEM. 
Asterisks indicate significant differences from prechallenge values 
(*P<0.05;**P<0.01).  
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Table 5. Number of infected mammary glands shedding Streptococcus uberis at 
different time points after challenge.  
 
 
Number of challenged infected 
mammary glands shedding S. uberis Hours after 
challenge Holstein cows1 
(n=8) 
Jersey cows2 
(n=8) 
0 0 0 
12 7 0 
18 7 0 
24 6 0 
36 3 4 
42 4 5 
48 3 6 
60 6 7 
66 6 8 
72 6 7 
84 6 8 
90 7 8 
96 8 8 
108 8 8 
114 8 8 
120 8 8 
144 7 5 
168 3 6 
 
1 Holstein cows received an inoculum dose of 10,500 CFU. 
2 Jersey cows received an inoculum dose of 6,650 CFU. 
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Figure 2. Number of somatic cells (log10/ml) in milk from mammary glands of 
cows challenged with Streptococcus uberis. Data are means ± SEM. Asterisks 
indicate significant differences from prechallenge values (*P<0.05;**P<0.01; 
***P<0.001). 
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peak concentration at 120 hours after challenge, bacterial numbers began to 
decline; this coincided with initiation of antibiotic therapy in 15 of the 16 infected 
mammary glands between 120 and 168 hours after challenge. Streptococcus 
uberis was not isolated from 4 challenged mammary glands that did not become 
infected, or from unchallenged control mammary glands. 
Leukocyte recruitment to infected mammary glands, as indicated by an 
increase in the number of somatic cells in milk, began at 18 hours after challenge 
(P<0.001; Figure 2) and continued throughout the sampling period. Before 
challenge, the number of somatic cells averaged 4.27 log10 /ml; 42 hours after 
challenge, even when no clinical signs were observed and no bacterial growth 
had been detected, number of somatic cells in milk increased 100-fold (6.3±0.18 
log10/ml) and continued to increase to a maximum number of 6.76±0.18 log10/ml 
at 120 hours. Challenged mammary glands which did not become infected (n=4) 
exhibited a significant increase in number of somatic cells (P<0.01; Figure 2). 
However, the magnitude of the increase was not as great as challenged 
mammary glands that became infected. No significant changes in the number of 
somatic cells in milk from unchallenged control mammary glands were detected. 
 
Leukocyte counts in peripheral blood 
Blood leukocyte counts varied greatly from cow to cow; however, there was a 
significant decrease in total blood leukocyte counts at 72 hours after challenge 
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(P=0.05; Figure 3). After that, blood leukocyte counts remained suppressed and 
did not return to baseline levels until 168 hours after challenge. 
 
Tumor necrosis factor-α 
During S. uberis experimental infection, TNF-α concentrations in whey 
from infected mammary glands increased significantly by 66 hours following 
bacterial challenge (P<0.01; Figure 4), and remained significantly elevated 
throughout the remainder of the sampling period. Peak TNF-α concentrations 
were observed at 120 hours after challenge (461±76 pg/ml). One of four 
challenged, uninfected mammary glands exhibited a slight increase in TNF-α 
concentrations; the remainder of the challenged, uninfected mammary glands 
had TNF-α concentrations below the detection limits of the assay. Only trace 
amounts of TNF-α were detected in whey from prechallenge samples and in 
whey from unchallenged control mammary glands. 
 
Interleukin-1β 
Concentrations of IL-1β in whey from mammary glands experimentally infected 
with S. uberis increased significantly by 66 hours after bacterial challenge 
(P<0.01; Figure 5). Concentrations of IL-1β fluctuated considerably from 66 to 
144 hours after challenge, however IL-1β concentrations during these times were 
still significantly (P<0.01) higher than prechallenge concentrations. Highest IL-1β  
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Figure 3. Leukocytes in blood (cells/ml (log10)) from cows experimentally infected 
with Streptococcus uberis (n=9). Data are means ± SEM. Asterisks indicate 
significant differences from prechallenge values (*P=0.05). 
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Figure 4. Concentrations of tumor necrosis factor-α (TNF) in whey from 
mammary glands challenged with Streptococcus uberis. Data are means ± SEM. 
Asterisks indicate significant differences from prechallenge values (*P<0.05; 
**P<0.01). 
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Figure 5. Concentrations of Interleukin-1β (IL-1) in whey from mammary glands 
challenged with Streptococcus uberis. Data are means ± SEM. Asterisks indicate 
significant differences from prechallenge values (*P<0.05; **P<0.01). 
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concentrations were observed at 90 hours after bacterial challenge (2.97±0.53 
ng/ml). The 4 challenged, uninfected mammary glands exhibited an increase in 
IL-1β concentrations, and the pattern appeared to be similar to that of challenged 
infected mammary glands. However, the increase in IL-1β concentrations in 
challenged uninfected mammary glands was not significant (P>0.05). Very low 
concentrations of IL-1β were detected in control unchallenged mammary glands.  
 
Interleukin-8 
The concentration of IL-8 in whey was measured at all time points in 
Holstein cows and daily in Jersey cows. The concentration of IL-8 was 
significantly elevated in mammary secretions from challenged infected mammary 
glands at 66 hours after bacterial challenge (P<0.01; Figure 6). Concentrations of 
IL-8 fluctuated considerably throughout the remainder of the experimental period. 
Peak IL-8 concentrations (34.6±6.8 pg/ml; P<0.001) were observed at 120 hours 
after challenge. No IL-8 was detected in challenged, uninfected mammary glands 
or in unchallenged control mammary glands. 
 
Adhesion molecule expression on blood neutrophils 
Adhesion receptor expression of CD11b, CD18 and CD62 was measured 
in Holstein cows only and is shown in Table 6. Expression of CD11b, the α-chain 
from the Mac-1 integrin, tended to show a slight upregulation at 84, 90 and 114  
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Figure 6. Concentrations of interleukin-8 (IL-8) in whey from mammary glands 
challenged with Streptococcus uberis. Data are means ± SEM. Asterisks indicate 
significant differences from prechallenge values (*P<0.05; **P<0.01). 
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Table 6. Mean fluorescence intensity (MFI) of CD11b, CD18 and CD62 adhesion 
molecules on blood polymorphonuclear leukocytes following experimental 
challenge with Streptococcus uberis. 
 
 
MFI1 
Hours CD11b2 CD18 CD62 
0 4.6a 70.8a 5.5a 
12 6.7a 61.3a 5.8a 
18 4.9a 73.4a 4.3a 
24 7.1a 66.4a 6.3a 
36 6.7a 70.1a 4.7a 
42 6.3a 66.8a 3.7a 
48 5.7a 84.8b 4.9a 
60 4.8a 73.3a 4.9a 
66 6.0a 78.0a 8.1a 
72 7.1a 66.3a 6.9a 
84 7.6b 74.2a 5.3a 
90 8.6b 76.3a 6.9a 
96 6.4a 48.9c 6.7a 
108 5.5a 44.2c 15.2b 
114 10.0b 42.9c 8.7a 
120 5.4a 42.6c 4.2a 
144 4.8a 36.8c 4.5a 
168 4.8a 31.4c 5.1a 
SE3 1.3 5 1.7a 
 
a,b,c Values within the same column with different superscript differ (P<0.05). 
1Mean fluorescence intensity (MFI) was measured by flow cytometry.  
2MFI for CD11b showed a trend toward significance (P=0.1). a,b,c Values within this column with 
different subscript differ (P<0.05) after analysis through specific contrasts.  
3SE=standard error of the mean. 
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hours after challenge (P=0.1). When these data were evaluated through specific 
contrasts, CD11b expression was significantly higher (P<0.05) at 84, 90 and 114 
hours after challenge. The mean fluorescence intensity for CD18, the β-chain of 
the Mac-1 integrin, increased 20% by 48 hours after experimental challenge 
(P<0.05). This was followed by a sharp decrease in CD18 MFI 96 hours after 
challenge which continued until the end of the sampling period at 168 hours after 
challenge (P<0.01). Expression of CD62 fluctuated somewhat after bacterial 
challenge, and at 108 hours after challenge a significant increase in CD62 
expression was observed (P<0.05). 
 
Correlation coefficients 
A moderate positive correlation was observed between concentrations of 
TNF-α, IL-1β and IL-8 in whey, bacterial and somatic cell numbers and the 
presence of clinical signs of mastitis and from challenged infected mammary 
glands (Table 7). 
 
DISCUSSION 
 
Streptococcus uberis is an environmental mastitis pathogen that accounts 
for a significant proportion of IMI in lactating and nonlactating dairy cows. The 
present study was conducted with cows in early lactation, a time when mammary 
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Table 7. Correlation coefficients between different clinical and bacteriological 
parameters of infection during experimental Streprococcus uberis mastitis. 
 
 
 Correlation coefficients 
 IL-1β1 IL-82 Mammary 
score 
Milk 
score 
Temperature Micro3 SCC4 
TNFα5 0.62b 0.63b 0.53b 0.41b 0.35b 0.48b 0.40b 
IL-1β  0.56b 0.52b 0.50b 0.23b 0.57b 0.50b 
IL-8   0.47b 0.42b 0.24b 0.45b 0.38b 
Mammary 
score 
   0.82b 0.11a 0.43b 0.48b 
Milk score     -0.14a 0.42b 0.46b 
Temperature      0.27b 0.18b 
Micro       0.53b 
 
1IL-1β= interleukin-1β 
2IL-8= interleukin 8 
3Micro= enumeration of Streptococcus uberis in milk 
4SCC= number of somatic cells in milk 
5TNFα= Tumor necrosis factor- α 
a P>0.05 
b P<0.05 
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glands are highly susceptible to new S. uberis IMI (Smith et al., 1985; Todhunter 
et al., 1995; Jayarao et al., 1999). The bacterial strain used to cause 
experimental S. uberis infection (UT888) induced clinical mastitis in the majority 
of challenged mammary glands, as reported previously (Fang et al., 1998a; 
Hockett et al., 2000).    
The objective of this study was to study the dynamics of leukocytes and 
inflammatory cytokines during experimentally-induced S. uberis mastitis in order 
to gain a better understanding of the pathogenesis of this disease in lactating 
dairy cows. The process of leukocyte recruitment and cytokine production during 
mastitis has been studied extensively using gram-negative infection models, 
such as mammary gland bacterial challenge with E. coli and Klebsiella 
pneumoniae (Rose et al., 1989; Shuster et al., 1996; Shuster et al., 1997; Blum 
et al., 2000; Riollet et al., 2000), or endotoxin infusion (Shuster et al., 1993; 
Rainard and Paape, 1997; Paape et al., 2002).  To our knowledge, this is the first 
report of cytokine production during IMI with S. uberis. The present study was 
conducted to determine the characteristics of the host response to IMI with S. 
uberis, a gram-positive environmental mastitis pathogen, which differs greatly 
from E. coli and other gram-negative pathogens in virulence, growth 
characteristics and ability to persist in the udder environment. 
Data from studies using the E. coli mastitis model, to which most 
comparisons have to be made due to the extensive information published on it, 
differs considerably from results of the present study. Probably, one of the more 
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important differences is the clinical course of infection. In the present study, 
clinical signs of mastitis were not detected until 72 to 108 hours following 
challenge. With the E. coli experimental infection model, clinical signs were 
evident within the first 8-16 hours after challenge, and signs are usually resolved 
without any therapeutic intervention within the first week after challenge (Hill et 
al., 1978; Shuster et al., 1997). 
Bacterial challenge of mammary glands with S. uberis UT888 provoked 
clinical mastitis in 16 of 20 challenged mammary glands. Appearance of clinical 
signs coincided with detection of large numbers of bacteria (>5,000 CFU/ml) in 
challenged mammary glands. Large numbers of bacteria (>5,000 CFU/ml) in milk 
were not detected until 84 hours after challenge, suggesting a lag phase in the 
ability of S. uberis to adapt and grow in the mammary gland. One possible 
explanation for this lag phase is that S. uberis may require a period of adaptation 
to the mammary environment, after which it is able to colonize the mammary 
gland. Streptococcus uberis is highly auxotrophic and depends on acquisition of 
several amino acids and other nutrients to grow successfully (Leigh, 1994b). Milk 
from lactating mammary glands is deficient in free or peptide associated amino 
acids. In order to infect the mammary gland S. uberis must possess a 
mechanism to acquire amino acids for growth. Leigh (1993) demonstrated that S. 
uberis was capable of converting plasminogen to plasmin which in turn degraded 
casein and generated by-products needed for optimal bacterial growth. 
Furthermore, a plasminogen activator, designated PauA, was isolated from S. 
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uberis (Leigh, 1994b). Other studies of experimental S. uberis IMI with a different 
strain (S. uberis O140J;Hill, 1988; Smits et al., 1998) suggest a similar lag phase 
although of shorter duration, probably due to a higher pathogenicity of the strain 
used. Nevertheless, our findings and data from other studies (Hill, 1988; Smits et 
al., 1998) suggest that upon intramammary inoculation, S. uberis requires some 
time to adjust to the mammary gland environment. Bacteria may then produce 
plasminogen activator which would activate plasmin and therefore allow better 
nutrient availability for optimal growth. This adaptation period apparently 
needed by S. uberis is in marked contrast with the remarkable ability of E. coli to 
grow in the mammary gland environment even 2 hours after inoculation into the 
mammary gland (Shuster et al., 1995; Shuster et al., 1996; Riollet et al., 2000). 
In contrast to the delay in increases of bacterial numbers, the number of 
somatic cells in milk increased significantly as early as 18 hours after challenge 
with S. uberis, and were 100-fold greater than prechallenge values at 48 hours 
after challenge, when S. uberis was still detected in very low numbers (<100 
CFU/ml). This would suggest inability to control growth of S. uberis in the 
mammary gland in spite of massive leukocyte infiltration from the bloodstream. 
Interestingly, this contrasts with findings using the E. coli experimental infection 
model, where bacterial numbers increase tremendously during the first hours of 
infection without apparent recognition by the host and therefore minimal 
leukocyte recruitment into the mammary gland (Shuster et al., 1995; Shuster et 
al., 1996; Riollet et al., 2000). 
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Based on our findings, it seems that host recognition of S. uberis during 
the initial stages of infection is not impaired, as demonstrated by the significant 
increase in the number of somatic cells in milk from challenged mammary glands 
within the first 24 hours after challenge. This is in agreement with other studies 
(Thomas et al., 1994; Smits et al., 1998). Phagocytosis by PMN is a crucial 
process in the elimination of E. coli (Hill et al., 1978) and S. aureus (Schalm et 
al., 1976) from the bovine mammary gland. The inability of PMN to phagocytose 
and kill certain strains of S. uberis has been reported in vitro (Leigh and Field, 
1991; Leigh and Field, 1994) and in vivo (Thomas et al., 1994).  Resistance of S. 
uberis to the bactericidal action of PMN in vitro was induced by growth of 
bacteria in media containing casein-derived amino acids and peptides (Leigh and 
Field, 1991) which may mimic the state within the mammary gland during 
infection. In a study by Thomas et. al. (1994) where pathologic findings of S. 
uberis infection were evaluated in vivo, a large neutrophil response was 
observed, and considered rather disproportionate to the number of bacteria 
present in milk. In the same study, very few bacteria were detected inside PMN, 
raising questions about the role of PMN in elimination of S. uberis from the 
infected mammary gland (Thomas et al., 1994). Results from our experiment also 
suggest that massive recruitment of PMN was not sufficient to eliminate S. uberis 
from infected mammary glands. 
A significant decrease in blood leukocyte counts was observed 72 hours 
after challenge with S. uberis. This decrease was not coincident with an increase 
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in the number of somatic cells, which occurred earlier, but it resembles findings 
by Smits et. al. (1998) where a significant decrease in blood leukocyte counts 
was observed 48 and 72 hours after S. uberis challenge. However, the study by 
Smits et. al. (1998) was conducted with a more virulent strain of S. uberis (strain 
O140J), which generally causes clinical disease between 24 and 60 hours after 
challenge (Hill, 1988; Thomas et al., 1994; Smits et al., 1998), earlier than 
observed in our experiment with S. uberis UT888. During experimental E. coli or 
endotoxin induced mastitis, where the inflammatory episode is more marked and 
sudden, the decrease in circulating blood leukocytes was simultaneous to the 
increase in the number of somatic cells in the udder (van Werven et al., 1999; 
Paape et al., 2002).  
The importance of cytokines in neutrophil recruitment is well established. 
However, cytokine production during S. uberis mastitis has not been 
documented.  In the present study, cytokine production was assessed in S. 
uberis challenged mammary glands as well as control unchallenged mammary 
glands. Interestingly, TNF-α, IL-1β and IL-8 were not detected in significant 
amounts in milk from infected mammary glands until 66 hours after challenge. All 
three cytokines measured were significantly elevated by 66 hours, when clinical 
signs still were not observed. However, at 66 hours after challenge, numbers of 
somatic cells had almost reached the maximum amount observed in this study 
(6.64 log10 SCC/ml). It has been demonstrated that, after migration into an 
inflammatory site, leukocytes begin to synthesize and release their own particular 
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set of cytokines within target tissue (Lloyd and Oppenheim, 1992). The massive 
influx of neutrophils into the mammary gland observed in our study may have 
been responsible for the simultaneous increase in cytokine concentrations at this 
time, since neutrophils, especially in large quantities, can be an important source 
of IL-1, TNF-α and IL-8 (Lloyd and Oppenheim, 1992; Xing et al., 1993).  
Peak TNF-α production was observed preceding peak clinical signs of 
mastitis. The TNF-α concentrations tended to increase gradually towards a peak 
at 120 hours. Great variability was observed between cows, but all challenged 
infected mammary glands showed detectable amounts of TNF-α. This contrasts 
with findings reported by Shuster et. al. (1997), where TNF-α bioactivity after 
challenge with E. coli was detected only in mammary glands with severe 
infection. Similarly, in a previous study by Shuster et al. (1993) where mammary 
glands were challenged with 10 µg of endotoxin, TNF-α activity was not detected 
in any of the challenged mammary glands. In our study, however, even 
mammary glands with moderate infections showed a significant increase in TNF-
α concentration. 
Low concentrations of TNF-α were detected as early as 12 hours after 
challenge in some mammary glands. The relative importance of the very low 
amounts of TNF-α found in some mammary glands in the early stages of 
infection is questionable, given the fact that concentrations were close to the 
lower detection limit of the assay (80 pg/ml) and that low levels of TNF-α were 
also found in some control unchallenged mammary glands. Nevertheless, TNF-α 
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biological activity has been observed at 10 pg/ml (Riollet et al., 2000), therefore 
activity of TNF-α in those samples or even in samples where no TNF-α was 
detected cannot be excluded. The TNF-α concentrations observed in our study 
were 30-fold smaller than those reported in E. coli or endotoxin experimental 
infections (Rainard and Paape, 1997; Riollet et al., 2000; Paape et al., 2002). Of 
note, comparisons between our study and others (Rainard and Paape, 1997; 
Riollet et al., 2000; Paape et al., 2002) may be of relative value due to 
differences in sample processing and time of analysis. Nevertheless, the findings 
that TNF-α concentrations were much lower than reported for E. coli 
experimental infections is not surprising, since other studies using different 
infection models with other infectious agents have shown little or no detection of 
TNF-α in spite of the presence of acute inflammatory signs (Baarsch et al., 1995; 
Tissi et al., 1999).  
Concentrations of IL-1β were also significantly elevated 66 hours after 
challenge with S. uberis. The pattern of increase of IL-1β was not gradual; this 
may be explained by differences in peak concentrations for individual mammary 
glands, which did not occur at the same time. Nevertheless, IL-1β remained 
significantly elevated until 120 hours. Interestingly, the 4 challenged mammary 
glands that did not become infected exhibited an increase in IL-1β concentrations 
in a pattern that was similar to that of infected mammary glands. This observation 
was surprising, considering that IL-1β is one of the acute phase cytokines 
responsible for clinical signs of inflammation (Baumann and Gauldie, 1994) , and 
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the 4 uninfected mammary glands did not show any clinical signs of 
inflammation. Interleukin-1β is one of the main cytokines found during 
experimental E. coli mastitis, with peak concentrations coinciding with the 
establishment of clinical signs (Shuster et al., 1997; Riollet et al., 2000). Since IL-
1β concentrations in control unchallenged mammary glands remained 
significantly lower than challenged mammary glands, findings of increased IL-1β 
concentrations and numbers of somatic cells in the 4 challenged uninfected 
mammary glands indicate that a mild inflammatory response did develop, but this 
response might have been enough to control the infection without any detectable 
clinical signs.  
Similar to TNF-α, small amounts of IL-1β were detected in some 
prechallenge and control unchallenged samples. Other investigators have 
reported low concentrations of TNF-α and IL-1β in secretions of noninflamed 
mammary glands or unstimulated mammary epithelial cultures (Sordillo et al., 
1990; Basolo et al., 1993; Shuster et al., 1997). The physiological significance of 
basal levels of these mediators is unknown. Shuster et. al. (1997) suggested that 
these mediators may contribute to the small influx of leukocytes that occurs even 
in uninfected mammary glands.  
Interleukin-8 was detected only in challenged mammary glands that 
became infected. The IL-8 increase was observed simultaneously to increases in 
TNF-α and IL-1β concentrations. Others have shown that TNF-α and IL-1β 
stimulate IL-8 secretion (Larsen et al., 1989; Boudjellab et al., 2000). Riollet et. 
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al. (2000) reported that high levels of IL-8 were found not only in mammary 
secretions but also in mammary cells from an E. coli infected cow, suggesting 
that the real quantities of IL-8 present in mammary secretions from infected 
glands may be underestimated. Since IL-8 has the ability to link itself to cell 
membrane receptors or to be rapidly internalized by cells (Marie et al., 1997), it is 
possible that larger amounts of IL-8 may have been produced, but not detected 
in the mammary secretion analysis. 
Cytokine involvement in leukocyte migration to an inflammatory site is well 
documented (Cybulsky et al., 1988; Baggiolini et al., 1989; Persson et al., 1993; 
Shuster et al., 1997). Cytokines mediate leukocyte recruitment to inflammatory 
sites by their chemotactic ability and by activation of adhesion molecules on 
circulating leukocytes and endothelial cells in the adjacent vasculature (Shuster 
et al., 1993; Shuster et al., 1997). Shuster et. al. (1997) reported that production 
of inflammatory mediators during experimental E. coli mastitis was coincident 
with a dramatic increase in the number of somatic cells, suggesting that upon 
bacterial recognition by the host, inflammatory mediators were produced and 
leukocytes recruited into the infected mammary gland. In our study, however, 
leukocyte recruitment into challenged mammary glands occurred earlier than 
significant local production of TNF-α, IL-1β or IL-8.  These three cytokines, on the 
other hand, are not the only soluble factors involved in the inflammatory 
response. Many other mediators such as histamine, serotonin, complement 
fragments, prostaglandins and leukotrienes may be responsible for increased 
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vascular permeability and leukocyte migration during the early phase of mastitis. 
Giri et. al. (1984) reported that prostaglandin concentrations in endotoxin-infused 
mammary glands preceded increased leukocyte counts. Additionally, Rose et. al. 
(1989) suggested that leukotriene B4 (LTB4) may be the principal neutrophil 
chemotactic factor in mastitis, although increased numbers of somatic cells 
preceded increases in milk LTB4. Furthermore, Shuster et. al. (1993) reported 
that swelling and increases in mammary gland permeability after endotoxin 
infusion preceded detection of TNF-α, IL-1β or IL-6, suggesting that these clinical 
changes were mediated by other inflammatory mediators. No information exists 
about the role of other inflammatory mediators in S. uberis mastitis.  
Rose et al. (1989) suggested that higher concentrations of inflammatory 
mediators in the tissue of a mastitic mammary gland may precede any increases 
observed in milk. The exact site of inflammatory mediator production in the 
infected mammary gland is unknown. Macrophages produce many inflammatory 
mediators upon bacterial stimulation, but epithelial cells can also generate a 
variety of inflammatory mediators upon interaction with bacteria (Agace et al., 
1993; Eckmann et al., 1993). A study showed that release of inflammatory 
cytokines by epithelial cells was directed toward the basolateral surface, the 
direction from which host defenses would be recruited (Eckmann et al., 1993). 
Specifically, mammary epithelial cells have been shown to produce IL-1β and IL-
8 in vitro (Boudjellab et al., 2000). Streptococcus uberis has been shown to 
adhere to and invade mammary epithelial cells in vitro (Matthews et al., 1994a; 
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Almeida et al., 1996). Therefore, as suggested by Shuster et. al. (1997), it is 
possible that cytokines were produced initially by epithelial cells upon contact 
with bacteria and that their concentrations may have been greater on the 
basolateral surface. As a consequence of this, their biological effects may have 
been induced in the interstitium. In this case, cytokine concentration in milk may 
have not been an accurate reflection of cytokine production and potential 
biological activity, and might explain the apparent delay observed in this study 
between cytokine detection in mammary secretions and leukocyte migration into 
challenged mammary glands. 
The role of adhesion molecules CD11b/CD18 and CD62 was also 
evaluated during S. uberis experimental infection. For CD11b, expression was 
slightly upregulated at 84, 90 and 114 hours after challenge. The increase in MFI 
was rather small, but differences of similar proportion have been reported during 
experimental S. uberis mastitis with strain O140J (Smits et al., 1998). The MFI 
for CD18 was upregulated 20% at 48 hours after challenge, similar to that 
reported by Smits et. al. (1998) during experimental S. uberis mastitis. In our 
study, however, increased expression of CD11b and CD18 was not coincident 
with an increase in number of somatic cells, which occurred earlier. Interestingly, 
Smits et. al. (1998) also reported that diapedesis of PMN from cows challenged 
with S. uberis was dramatically diminished, in spite of upregulation of CD11b and 
CD18. It is possible that other adhesion receptors may be involved in PMN 
migration into the mammary gland. The MFI for CD18 decreased dramatically 96 
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hours after challenge, and remained below prechallenge values. Since this is the 
period of time when cows were showing clinical signs, it is possible that 
endogenous release of cortisol upon onset of clinical signs caused 
downregulation of CD18 expression, as suggested by others (Burton and Kehrli, 
1995; Smits et al., 1998). Using the same mastitis model described in the present 
study, Hockett et. al. (2000; 2002a; 2002b) reported a significant increase in 
serum cortisol levels 96 hours after challenge with S. uberis UT888 and serum 
cortisol remained significantly elevated at 168 hours after challenge (Hockett et 
al., 2000; Hockett et al., 2002a; Hockett et al., 2002b). This time period between 
96 and 168 hours after bacterial challenge is coincident with the marked 
downregulation of CD18 observed in our experiment. Therefore, it is possible that 
increased serum cortisol may have caused downregulation of CD18. No 
significant variation was detected in CD62 expression, except for an 
unexplainable increase in MFI at 108 hours after challenge. 
In conclusion, this study provides insight into the inflammatory response 
during experimental S. uberis mastitis. Leukocyte recruitment into mammary 
glands was prompt and significant, though appeared to be ineffective in 
controlling the onset of infection. Intramammary infection with S. uberis elicited 
local production of cytokines, and peak concentrations of TNF-α, IL-1β and IL-8 
were reached once clinical signs had been established. Expression of adhesion 
molecule CD11b/CD18 was upregulated, but a significant increase in the number 
of somatic cells was observed before upregulation of CD11b/CD18. These 
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findings suggest that other factors may be involved in initial leukocyte recruitment 
into mammary glands after S. uberis infection, and that TNF-α, IL-1β and IL-8 
may be responsible, at least in part, for the observed clinical signs. Future 
studies focused on the early events that take place after bacterial challenge may 
help to elucidate the pathogenesis of S. uberis mastitis and the development of 
more effective control measures for S. uberis mastitis in dairy cows. 
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APPENDIXES 
  
Appendix 1. Enumeration of Streptococcus uberis (colony forming units/ml) in milk from mammary glands 
experimentally infected. 
Holstein challenged infected mammary glands1 Jersey challenged infected mammary glands2 Hours after challenge 
61 LR3 61 LF4 87 RF5 87 RR6 91 RF 91 RR 116 LR 116 LF 562LF 769RF 800RF 800LR 826RR 826LR 840RF 840LF 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
12 1100 300 1300 500 200 200 300 0 0 0 0 0 0 0 0 0 
18 2800 2500 0 1300 500 2700 3000 100 0 0 0 0 0 0 0 0 
24 2600 500 0 800 0 100 700 2300 0 0 0 0 0 0 0 0 
36 400 200 0 100 0 0 0 0 0 0 0 400 1900 300 500 0 
42 400 100 0 200 0 0 4800 0 15 51000 0 100 0 0 1600 1600 
48 700 0 2400 0 0 0 100 0 4250 27250 0 4750 700 0 2300 1750 
60 3900 5300 10000 2000 0 0 4100 2300 110000 55750 100 1200 0 1200 2750 30000 
66 1300 1300 6500 50000 0 0 17300 4400 270000 407500 100 2300 800 100 900 10000 
72 1000 1000 8000 7750 0 0 12800 6500 4750 975000 200 2600 900 0 5000 10250 
84 67500 37500 10000 10000 0 0 13000 46500 2275000 82500 200 10750 8900 1500 700000 25000 
90 40000 14500 19300 5000 7500 0 6750 4000 262500 1200000 600 9250 82500 3500 3250 6500 
96 14800 13800 7500 5000 2100 200 368000 24500 270000 2975000 3600 12500 12500 5500 24500 3250 
108 82500 3750 220000 16000 1700 2000 900000 1000000 690000 390000 500 625000 26500 500 975000 317500 
114 17300 21000 14000 208000 2900 2900 45300 5500 1300000 15500 2500 44250 5250 2500 21300 1800 
120 10500 6500 1400000 4000 5000 200 26800 363000 3025000 180000 40500 187500 1925000 1650000 290000 21750000 
144 210000 16800 0 165000 230000 800 87500 2850000 54500 0 20250 1825000 260000 300000 0 0 
168 0 0  0 8000 0 62500 5000 0 100 10000 2425000 100 100 0 0 
1 Holstein cows were challenged with 10,500 CFU/ml of S. uberis UT888. 
2 Jersey cows were challenged with 6,650 CFU/ml of S. uberis UT888. 
3 LR= Left rear mammary gland;4 LF= Left front mammary gland;5  RF= Right front mammary gland;6  RR= Right rear mammary gland. 
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Appendix 2. Timeline of events during experimentally-induced Streptococcus uberis mastitis.  
 
 
Hours  
0 12 18 24 36 42 48 60 66 72 84 90 96 108 114 120 144 168 
Clinical 
signs 
 
 Start on some cows Significant clinical signs            Peak 
 
 
            ATB1 
S. uberis in 
milk 
 Significant increase 
 
Peak   Begin              
            decrease 
Somatic 
cells 
                      Significant increase Peak, maintained  
Blood 
leukocytes 
 Small 
decrease 
 Decreased throughout, significant at 72 hours                        
TNF-α2 
 
            Significant increase 
Peak 
IL-1β3             Significant increase        Peak 
 
 
 
IL-84 
 
  Small increase            Significant 
            increase 
Significant increase               Peak 
CD11b 
expression 
             Upregulated     Upregulated 
CD18 
expression 
          Upregulated         Downregulated 
CD62 
expression 
  Upregulated 
1 ATB=antibiotic therapy. Three mammary glands received antibiotic therapy at 120 hours, 8 mammary glands received antibiotic therapy at 144 hours and 4 mammary glands 
received antibiotic therapy at 168 hours after intramammary inoculation with S. uberis. 
2 TNFα= tumor necrosis factor-alpha 
3 IL-1β= interleukin-1 beta 
4 IL-8= interleukin-8 
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